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1 MAGNESIUM 
 
1.1 Introduction  
Magnesium (Mg2+) is an essential ion to the human body, being the most abundant 
divalent intracellular cation in the cells, the second most abundant cellular ion next 
to potassium, and the fourth cation in general in the human body [1]. 
Total body magnesium (Mg) content in the average 70 kg adult is approximately 25 
g [2], of which 50-60% resides in bone, while the remaining 40 % are located extra- 
and intracellular [3].  
Inside the cell magnesium is responsible for a plethora of functions, from the 
activation of a variety of enzymes to the signal-transduction proteins. It is also 
required for trans-cellular ion transport, membrane stabilization, cytoskeletal 
activity, synthesis of carbohydrates, proteins, lipids and nucleic acids [3], [4]. 
Furthermore, cellular energy metabolism is strictly dependent on magnesium 
availability, since the functional ATP form is MgATP2- [5], [6]. 
As a consequence, being implicated in those reactions utilizing ATP or catalyzing the 
transfer of phosphate, Mg2+ plays a role in virtually every process in the cell [4]. On 
the base of these findings, is not surprising that reduction of magnesium availability 
is implicated in many human disease, such as hypertension, heart defects, nervous 
system disorder, muscle disease, atherosclerosis, diabetes and metabolic syndrome 
[3], [7], [8]. 
 
1.2 Mg2+ transport across biological membrane 
Total intracellular magnesium concentration ranging between 17 and 20 mM in 
mammalian cells [9]. The cellular distribution of magnesium is heterogeneous, with 
lower concentrations in the peripheral regions of the cytoplasm than in the 
perinuclear region [10]. The majority of cellular Mg2+ is bound to proteins, 
 phospholipids, nucleic acids and especially ATP [9], or it is sequestered within 
mitochondria and endoplasmic reticulum, which are the main intracellular Mg2+ 
stores. The majority of cytoplasmic Mg2+ is present in the form bound to ATP and 
phosphometabolites, so cytosol free ionized Mg2+ represents only a small amount, 
approximately 5% of the total cellular Mg. The free Mg2+ concentration is ≈0.2–1 mM 
[11], [12], and it is maintained below the concentration predicted from the 
transmembrane electrochemical potential. This control is achieved through a 
balance of Mg2+ uptake, intracellular Mg2+ storage and Mg2+ efflux. 
Taking into account that the membrane potential typically ranges from –40 mV to –
80 mV (negative on the cytoplasmic side) and that the extracellular concentration 
of magnesium is higher than its intracellular ones [13]–[15], uptake of Mg2+ into the 
cell can be mediated by channels or channel-like mechanisms.  
On the contrary, outward transport of cations takes place against the 
electrochemical gradient, therefore, Mg2+ extrusion must be accomplished by an 
ATP-dependent transporter or by an exchanger.  
Of great interest for the feature of Mg2+ transporters are the peculiar chemical 
properties of Mg2+, properties that make it unique amongst biological cations. 
Indeed, in the dissolved state, Mg2+ has two hydration shells, making its hydrated 
radius 400-times larger than its dehydrated radius, larger than that of other cations 
like Na+, K+, and even Ca2+ [16]. For instance, it is almost impossible for magnesium 
to pass through narrow channels in biological membranes because magnesium 
cannot be easily stripped of its hydration shell [2]. Steric constraints for magnesium 
transporters are also far greater than for any other cation transport system [16]: 
proteins transporting magnesium are required to recognize the large hydrated 
cation, strip off its hydration shell and deliver the bare ion to the transmembrane 
transport pathway through the membrane, a process that requires a lot of energy 
[8]. 
  
 
Figure 1.1: Mg2+ transport in vertebrate cells [17]. The figure depicted various 
proposed Mg2+ transporters and their predicted transport mechanisms: Mrs2, a 
mitochondrial Mg2+ uptake system that transports Mg2+ with mitochondrial 
membrane potential (channel transport mechanism based on similarity with yeast 
Alr family); TRPM7 channel kinase (channel transport mechanism), and MagT1 
(thought to be a plasma membrane Mg2+ transporter with an ion channel transport 
mechanism). SLC41A1/A2 (channel transport mechanism based on structural 
homology with prokaryotic MgtE transporters): SLC41A1 identified as the Na+/Mg2+ 
exchanger [18] represents an exchange mechanism which mediates Mg2+ efflux in 
vertebrate cells; SLC41A2 has been suggested as the responsible Mg2+ transporter 
in Golgi but its mode of operation is still uncovered. Mg2+ transport into both the 
endoplasmic reticulum and nucleus are very poorly characterized and hence are 
pictured simply as passive exchange mechanisms (Taken from Sahni et al, 2013). 
 
 
1.2.1 Mg2+ accumulation 
The majority of the recently identified Mg2+ entry mechanisms operate at the cell 
membrane level with two notable exceptions that favor Mg2+ transport across the 
membrane of mitochondria and Golgi system, respectively [15]. 
  
1.2.1.1 TRPM Channels 
Transient receptor potential (TRP) cation channels represent a large family of ion 
channels that are expressed in several organisms, tissues and cell types and act as 
important transducers in cellular communication network. The TRP superfamily is 
divided into six related sub family proteins, including the TRPM sub family members 
[19].  
The melastatin-related TRP family (TRPM) consists of eight members that can be 
group into four pairs based on amino acid sequence similarities: TRPM1/3, 
TRPM2/8, TRPM4/TRPM5 and TRPM6/7.  
TRPM7 and TRPM6 were the first Mg2+ channels identified in mammalian cells and 
they both shared the unique feature of a kinase domain belonging to the atypical 
family of alpha-kinases at their C-terminus fused to the ion channel domain for 
which they have been termed ‘chanzymes’ (channels plus enzymes) [20]. TRPM6 and 
TRPM7 are able to build heteromultimers [21], and share many biophysical and 
biochemical properties, but their kinase do not have identical substrate specificities. 
In particular, TRPM6 and TRPM7 both autophosphorylate threonine residues, but 
only TRPM6 crossphosphorylate TRPM7, and not the reverse [22].  
While TRPM7 is equally distributed in human tissues and organs, the expression of 
TRPM6 is localized in the colon and in the distal convoluted tubule of the nephron, 
where it represents the key protein in the transcellular pathway of intestinal Mg2+ 
absorption and renal reabsorption [23], although recent studies indicate that 
TRPM6 might have a broader expression pattern, specifically in cells of the immune 
system [24]. Moreover, impairment of TRPM6 expression has been associate to a 
genetic form of hypomagnesemia accompanied by hypocalcemia poorly restored by 
massive Mg2+ administration [25], [26].  
While TRPM7 shares a very high homology with TRPM6, genetical studies 
demonstrated that TRPM7 and TRPM6 fulfill non-redundant functions and that each 
channel contributes uniquely to the regulation of Mg2+ homeostasis [27]. 
Accordingly, they do not complement for each other’s deficiency in TRPM7-/- B 
lymphocyte [28], in TRPM6-/- and TRPM7-/-  mice [29], [30].   
 TRPM7 is important to ensure a rapid Mg2+ entry during G1 phase of the cell cycle 
and its activity is regulated by intracellular Mg2+ through a negative feedback 
mechanism [30]. It is considered a master regulator of cellular Mg2+ homeostasis 
and it is involved in a number of vital cellular processes in mammalian cells. 
Furthermore, recently TRPM7 has gaining increasing attention for its potential role 
in cancers as a new diagnostic and prognostic marker, in addition to known 
biomarkers [31].  
 
1.2.1.2 MagT1 
Currently, the only known selective plasma membrane Mg2+ transporter is MagT1. 
It has been demonstrated to be essential for vertebrate Mg2+ influx [32], and is 
broadly expressed in human tissues [33]. 
A recent study shows that in the situation of TRPM7-deficiency, eukaryotic DT40 B 
cells (chicken B-cell line) increase the expression level of  MagT1, indicating that 
MagT1 might compensate for the lack of TRPM7 [34]. A further study [33], 
characterizes MagT1 and TUSC3, its human paralogue, as major mechanisms of Mg2+ 
influx, as a knockdown of either MagT1 or TUSC3 significantly lowers the total and 
free intracellular Mg2+ concentrations in mammalian cell lines. Moreover, it is 
reported that magnesium, and in particular MagT1 channel, are key molecular 
players for T cell activation and cytotoxic activity [35].  
 
1.2.1.3 Claudins 
Claudin-16 was the first Mg2+ transporting protein to be identified in mammals, and 
is a member of the claudin family, which comprehends a group of tight junction 
proteins. 
Claudin-16 mediates paracellular Ca2+ and Mg2+ fluxes throughout the nephron, 
which is thought to be the main renal Mg2+ reabsorption mechanism.  
Mutations in Claudin-16 are responsible for a hereditary disease called 
hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), characterized 
by massive renal Mg2+ and Ca2+ wasting [36]. 
Recently another claudin isoform, Claudin-19, has been shown to be involved in the 
reabsorption of Mg2+ and Ca2+ [37]. This protein forms a heteromeric complex with 
 Claudin-16 at the level of the tight junction, with specific cation-selectivity. Point 
mutations of both of these proteins affect the heteromeric interaction leading to 
development of FHHNC [5]. 
 
1.2.1.4 CNNM Family 
The cyclin M (CNNM) family, also known as the ancient conserved domain protein 
(ACDP) family, consists of four proteins (CNNM1–4 or ACDP1–4) in mammals [38]. 
The name results from a weak sequence similarity that is shared with the cyclin 
family, although a cyclin-like function has never been shown for CNNM1–4 [39]. 
CNNMs reside at the plasma membrane where CNNM1 has been identified as a 
cytosolic copper chaperone, CNNM2 was shown to mediate Mg2+- sensitive Na+ 
currents during the regulation of renal Mg2+ uptake, CNNM3 and CNNM4 have been 
linked with serum Mg2+ levels [40], [41]. 
Mutations in the CNNM2 gene cause familial dominant hypomagnesaemia, a rare 
human disorder characterized by renal and intestinal Mg2+ wasting [41], and 
CNNM2 has been also associated with coronary artery disease and hypertension 
[42].  
Recently, it has been found that CNNM3 activity is regulated by the oncogene PRL2 
and that his interaction could be essential for Mg2+ influx that drives tumour 
progression. Taking into account these results, CNNM3 seems to be involved in 
cancer [43]. 
 
1.2.1.5 MRS2 
The only known transporter in eukaryotic cells responsible for Mg2+ uptake into 
mitochondria is MRS2. Mg2+ transport into the mitochondrial matrix occurs via 
electrophoretic uniport, driven by the mitochondrial membrane potential [44]. 
MRS2 protein is required for normal mitochondrial Mg2+ homeostasis and function, 
and also for the stability of mitochondrial respiratory complexes [45]. 
MRS2 expression has also been associated to drug resistance of gastric cancer cells 
where it was observed an up-regulation of this channel in doxorubicin resistant cells 
respect to the sensitive counterparts; vice versa, MRS2 knock down partially reverse 
the MDR phenotype in cells with acquired resistance [46]. 
 Taking into account these findings, it seems that MRS2 overexpression might 
counteract drug-induced apoptosis by increasing magnesium influx into 
mitochondria [47]. 
 
1.2.1.6 MMgTs 
The membrane Mg2+ transporter (MMgTs) gene family comprehends two protein, 
MMgT1 and MMgT2, with no known similarities to other transporters. MMgT1 and 
MMgT2 are specifically located in the Golgi complex and post-Golgi vesicles, in 
which they contribute to regulate Mg2+-dependent enzymes involved in proteins 
assembly. MMgT1 and MMgT2 transcripts are present in a wide variety of tissues, 
suggesting a housekeeping role for the two transporters in cellular Mg2+ 
metabolism. Moreover, the small size of these proteins suggests that they form 
homo- and/or hetero-oligomeric channels to favor Mg2+ permeation [9], [36].  
 
1.2.2 Mg2+ extrusion 
Two mechanisms were postulated to mediate Mg2+ extrusion. The first mechanism 
uses the Na+ concentration gradient as only energy input for the extrusion of Mg2+ 
and the mechanism was therefore named Na+-dependent exchanger. To mediate 
Mg2+ extrusion, Na+-dependent exchanger requires a physiological concentration of 
Na+ in the extracellular milieu, suggesting that the mechanism occurs through a 
Na+/Mg2+ exchanger by the extrusion of 1 Mg in exchange with 2 Na [15]. Recently, 
this exchanger has been molecularly identified as being the solute carrier family 41 
member A1 (SLC41A1) [18]. 
The second mechanism is Na+ independent and still remains poorly characterized. 
Different cations (e.g. Ca2+ or Mn2+) and anions (e.g. HCO3-, Cl-) are suspected to act 
as counter-ions in this process [48]. 
 
1.2.2.1 SLC41 Family 
The 41st family of solute carriers (SLC41) comprises three members, SLC41A1, 
SLC41A2 and SLC41A3, which have been found in all eukaryotes and are distantly 
homologous to bacterial Mg2+ channel MgtE [49]–[51]. 
 SLC41A1 is the only member that has been well characterized at the molecular and 
physiological level, and as mentioned above, it has been recently identify as the 
Na+/Mg2+ exchanger mediating Mg2+ transport across the plasma membrane [18]. 
Little is known about the exact function of SLC41A2 and SLC41A3, however, based 
on their homology with A1, it could be assumed, that both A2 and A3 also function 
as Mg2+/(X+) carriers, and in particular SLC41A2 seems to be primarily functional in 
the membranes of the intracellular compartments mediating Mg2+ subcellular 
transport [52].  
 SLC41A1 is ubiquitously expressed in human cells, while no informations existing 
about the expression of human A2 and A3 across human tissues and organs. 
Several reports have recently been published linking SLC41A1 (as a key component 
of cellular and perhaps also of systemic Mg2+ homeostasis) with serious human 
illnesses. Among the most exciting findings has been the discovery that A1 is part of 
a novel Parkinson’s disease (PD) susceptibility locus PARK16, and it seems that 
single nucleotide-polymorphisms (SNPs) of SLC41A1 are linked to PD [53], [54].  
Moreover, a link between preeclampsia and elevated expression of A1 in placental 
tissues has been recently demonstrated, suggesting that A1 carried out an important 
role in the pathophysiology of this disease [55]. 
 
1.3 Hormonal Regulation of Mg2+ Transport and Homeostasis 
Under resting conditions, mammalian cells tightly regulate their basal Mg2+ content 
within the range of 17-20 mM even when a major trans-membrane gradient is 
artificially imposed [9].   
At the same time, several papers demonstrated the occurrence of large Mg2+ fluxes, 
in either direction across the cell membrane and the membrane of intracellular 
stores following metabolic stimulations by hormonal and pharmacological factors 
including β-agonists, growth factors, and insulin [56]–[58]. 
 1.3.1 Mg2+ Extrusion 
In the majority of eukaryotic cells, hormones or agents that increase intracellular 
cAMP level, such as catecholamines, glucagon, arachidonic acid or forskolin, provoke 
a significant extrusion of Mg2+ into the extracellular space by the activity of 
Na+/Mg2+ exchangers. Indeed, it has been shown that many different cellular types, 
from cardiac cells [59] to lymphocyte [60] among other cells [61], respond with a 
massive Mg2+ efflux returning to baseline levels within 8 minutes from the 
application of the stimulus. This large and temporally limited Mg2+ fluxes may lead 
to a significant redistribution and mobilization of Mg2+ across the cells and cell 
compartments, which can affect many cellular functions and metabolic pathways.  
The key role of cAMP mediated extrusion is further corroborated by the observation 
that pre-treatment of cells with hormones or agents that decrease cAMP levels, are 
able to prevent cellular Mg2+ mobilization [56], [60].  
Furthermore, either the removal of extra cellular Na+ or its replacement with non-
selective Na+/Mg2+ exchanger inhibitors like imipramine and quinidine, abolishes 
the Mg2+ extrusion almost completely. These clearly indications that cAMP-
mediated Mg2+ extrusion occurs via Na+/Mg2+ exchanger, were the basis of the 
experimental demonstration that  human SLC41A1 gene encodes for the Na+/Mg2+ 
exchanger [18]. 
Mg2+ extrusion can also occurs by cAMP-independent mechanisms following α1-
adrenergic stimulation, since it is reported that α1-adrenergic receptor-mediated 
Mg2+ extrusion in perfused livers and isolated hepatocytes, requires an increase in 
cytosolic Ca2+ concentration and the activation of Ca2+/calmodulin intracellular 
signaling [62]. This mechanism evidences the linking between Ca2+ signaling and 
Mg2+ homeostasis. 
 
1.3.2 Mg2+ accumulation 
The mechanisms that regulate magnesium accumulation inside the cells are still 
largely unknown. The main pathway for Mg2+ uptake in mammalian cells is the 
activation of protein kinase C (PKC) signaling. Several research groups have 
 provided evidence about the supporting role of PKC in mediating Mg2+ accumulation 
[63].  
The linking between PKC activation and Mg2+ accumulation is further corroborate 
by the observation that Mg2+ uptake does not occur under condition in which cells 
are treated with known inhibitors of PKC, for example staurosporines [64]. 
However, several lines of evidence indicate that other pathways are involved in the 
regulation of Mg2+ entry such as MAPKs and EGF signaling [65]. Indeed, the 
inhibition of MAPKs signaling hampers Mg2+ entry and blocks cell cycle progression 
by affecting cyclin activity, while EGF controls the TRPM6 channel expression in the 
apical domain of renal epithelial cells and the consequently Mg2+ reabsorption [66]. 
Indirect evidence of Mg2+ homeostasis regulation by EGF is provided by the induced 
Mg2+ wasting and hypomagnesemia following by the use of antibodies against EGF 
for the treatment of several form of colon cancer [67], [68]. 
 
1.4 Magnesium and Cell Proliferation 
Compelling evidences show that magnesium content is directly correlated to 
proliferation. The articulated phenomenon of cell proliferation begins following the 
binding of hormones or growth factors to their specific surface receptor. As a 
consequence, the mitotic signals start a phosphorylation-based signal cascade   
which leads to the activation of transcription factors crucial for the protein 
synthesis, which is required for the initiation of DNA synthesis and mitosis.  
Mg might reasonably be involved in every single step of the mitogenic stimuli: from 
receptor-mediated mitotic signals and transphosphorylation reactions to gene 
transcription and protein synthesis occurring prior to cell division [69]. Moreover, 
key enzymes of DNA duplication, as polymerase and ligases, required Mg-ATP2- for 
their activity, and finally Mg is involved in the cytoskeleton re-arrangement leading 
to the formation of the mitotic spindle and cytokinesis [70].   
The plethora of functions that magnesium carry out on cell proliferation regard also 
the stabilization of DNA structure and regulation of the opening/closing of ion 
channels for the change of pH and calcium concentration prior to cell division (Fig. 
1.2).  
  
Figure 1.2: Pathway of cell proliferation and its regulation by magnesium [71]. 
All step leading to cell proliferation, from signal transduction to mitosis, may be 
affected by magnesium availability. At the molecular level, low Mg up-regulates p27 
and p21 inhibitory proteins, leading to cell cycle arrest through inhibition of 
cyclin/CDK complexes and consequent inhibition of the Rb (retinoblastoma)-
regulated restriction point (Taken from Wolf et al, 2008).  
 
 
Experimental evidence clearly indicates that growing cells contain more Mg than 
resting ones [72], coherently with the promoting role of Mg2+ on protein and DNA 
synthesis.  
However, the dependence of growth rate to extracellular magnesium availability 
vary from the different cellular types analyzed. In general, normal diploid cells are 
highly sensitive to changes in magnesium availability: endothelial cells and 
fibroblasts decreased their growth rate to a considerable extent when the cells were 
maintained in 0.1 mM extracellular Mg2+ [73], [74]. Conversely, immortalized cells, 
showed a 50% growth inhibition only upon exposure to 0.05 mM Mg2+ [75], while 
tumour cells, as for example HL60 leukaemia cells, proved to be the most resistant 
ones, showing an unaltered growth rate at 0.05 mM extracellular Mg2+ [76].  
Furthermore, it has been shown that incubation of cells in low magnesium 
concentrations causes growth arrest, resulting in an increased percentage of cells in 
G0/G1 phase, a decrease percentage of cells in S phase and, occasionally, a slightly 
 increased percentage of cells in G2/M phase [77]. However, the re-addiction of Mg2+ 
caused a rapid and relevant rise in the proliferating rate, suggesting that cell cycle 
arrest is reversible [78]. At the molecular level, low Mg  availability trigger the up-
regulation of  the cell cycle inhibitor p27 [75] and p21 [79]. In parallel, cyclins D and 
F, which promote cell cycle progression, decrease [80].  
On the contrary increasing the amount of extracellular Mg2+ induces activation of 
cell cycle, which is trigger by MAP kinases protein, leading to up-regulation of cyclins 
D and F and decreased expression of p21 and p27 [66]. 
These findings suggest that Mg2+ availability affects cell cycle by influencing the 
transcription of the cell cycle regulatory proteins such as p21 and p27, cyclins and 
CDKs. 
 
Harry Rubin postulated the theory of “Membrane Magnesium Mitosis”, suggesting 
that cytoplasmic free Mg2+ is the unifying regulatory element of cell growth and 
proliferation. On the basis of this theory, membrane perturbations induced by 
growth factors causes a decrease of Mg2+ binding affinity for negatively charged 
membrane sites and result in increased intracellular Mg2+ levels, which triggers in 
turns protein synthesis and a number of MgATP2- dependent reactions. The 
products of these reaction further enhanced protein synthesis and the related DNA 
synthesis, ultimately leading to cell division [81], [82].  
 
1.5 Magnesium and Cell Differentiation 
While clear evidence has been provided about the relevance of magnesium in 
driving cell proliferation, little is known about its involvement to the modulation of 
cell differentiation [83]. Data presents in literature are relatively few and 
discordant. Differentiation is an extremely complex framework governed by 
numerous and different factors as receptor-mediated stimuli, growth inhibitors, 
contact inhibition, intercellular junctions. Moreover, it requires the activation of 
cell-specific genetic programs that can be differentially affected by Mg [84]. 
As regard the consequence of Mg restriction, some studies described that low 
extracellular magnesium promotes cell differentiation, while others reach opposite 
 conclusions. It is reported that Mg deficiency reversibly antagonized the 
differentiation of HL60 cells exposed to differentiating agents such as DMSO and 
retinoic acid [76], [85] and akin to these observations it was also found that Mg 
restriction retards phorbol ester-induced differentiation in U937 cells [83]. In 
contrast to the above findings, it has been shown that Mg-restricted media rapidly 
reversed the transformed phenotype of fibroblasts [86], and in C2C12 myogenic 
cells, Mg deficiency upregulated Myod, one of the transcription factors fundamental 
for myogenesis [87]. 
Moreover, also the exposure to high extracellular Mg has provided discordant 
results. It was observed that excessive extracellular Mg blocks pre-osteoblast 
differentiation [88] and inhibits matrix mineralization in the prechondrogenic cell 
Line ATDC5 [89], while in U937 high extracellular Mg accelerates cell differentiation 
[83]. 
In pancreatic islet RINm5F cells, both low and high extracellular Mg impaired insulin 
synthesis without altering cell morphology, suggesting that in this cells the effects 
of Mg may be confined to the induction of functional rather than morphologic 
differentiation [90].  
Again, different results were obtained in endothelial cells and pre-adipocytes were 
differentiation seems to be independent from extracellular Mg [83]. 
Together, these findings suggests that fundamental differences exist between 
various cell types in the contribution of Mg to cell differentiation. The relationship 
between Mg and cell differentiation thus remains open to debate and further 
experimental evidences are certainly needed to shed new light on this issue. 
 
  
  
 2 TECHNIQUES TO MEASURE MAGNESIUM 
 
2.1 Introduction 
Although the biological relevance of magnesium is now widely recognized, a full 
understanding of cellular magnesium homeostasis has not been achieved. This can 
partly be attributed to the lacking of available techniques and methodologies able to 
rapidly and accurately measure changes in cellular Mg content. Furthermore, 
mammalian cells tightly regulate magnesium ion content through specific 
mechanisms controlling Mg2+ entry and efflux across the cell membrane and the 
membrane of various cellular organelles, as well as intracellular Mg2+ buffering 
under resting condition, and following hormonal and metabolic stimuli [91]. Indeed, 
magnesium buffering within the cytoplasm at concentration in the sub-millimolar 
range implying that Mg2+ fluctuations could only be traced by techniques able to 
sense minor changes [92].   
2.2 Principle techniques to determine magnesium  
Flame Atomic Absorption Spectroscopy (F-AAS) has been historically the first and 
most common approach to assess total cellular magnesium in cell or tissue acidic 
extracts. Even if is still considering the reference technique for the quantification of 
the total intracellular magnesium, it requires large samples (at least millions of cells 
or several milligram of tissue). Other more sensitive techniques require smaller 
sample sizes, such us Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) and 
Graphite Furnace AAS (GF-ASS). These techniques indubitably offer improved 
detection limits, however require instrumentations not easily available in any 
laboratory, more complex analytical procedures and specific technical skills and 
competencies [1][2]. Moreover, the major limitation of all these methods is that 
magnesium free and bound forms cannot be discriminated and information about 
intracellular distribution in whole cells can only be derived indirectly by cell 
permeabilisation or subcellular fractioning [92]. 
 On the other hand, free Mg2+ can be measured from the chemical shift of the Mg-ATP 
peak by 31P Nuclear Magnetic Resonance (NMR) spectroscopy [95], [96], by electron 
probe microanalysis [97], and by ion-selective microelectrodes [98]. All these 
techniques have different fields of application, depending on the cells or tissues 
studied, but they all present serious limitations.  
In particular, 31P NMR relies on the fact that most magnesium in the cytosolic matrix 
is bound to ATP. Therefore, variation in the acquired chemical shift associated to the 
phosphorylated molecule present in the cytoplasm including Inorganic Phosphate 
(Pi), Phosphocreatine (PCr) and ATP depends on the Mg2+ concentration [99]. 
31P NMR allows an accurate measurement of cytosolic free Mg2+ in vivo but supplies 
no information on the total magnesium concentration and its distribution among 
cellular subcompartments. 
Magnesium content in different subcellular compartments can be evaluated by 
electron probe microanalysis in freeze-died cryosections. This technique is invasive 
and again does not provide information on free and bound Mg2+ and does not allow 
kinetic measurements of Mg2+ fluxes [100]. At last, ion-selective microelectrodes 
allow direct measurement of free Mg2+ in single cells or plasma, but this technique 
discloses problems of interference with other ions (Ca, K), requires very large 
amount of cells for intracellular measurement and is a method technically difficult 
in single cells [101].  
Considering the serious limitation of the available techniques, suitable tools for 
studying the role of magnesium in cell processes require the ability to monitoring 
the dynamics of its concentration in living cells with both spatial and temporal 
resolution.  
Recently, fluorescent probes have been widely used as tools for the dynamic 
measurement of ion distribution and concentration in cells [102]. They are highly 
sensitive and offer imaging by fluorescent microscopy in an easier and less cell 
damaging way than other methods (e.g. ion-selective electrodes, NMR techniques) 
[103]. 
In this context, fluorescent probes, thanks to their sensitivity, represent the method 
of choice to detect even minor changes in ion concentration. 
 2.3 Fluorescent chemosensors 
Chemical sensing using fluorescence to signal a molecular recognition event was 
first shown by Tsien et al. in the early 1980s reporting the synthesis of the first 
fluorescent calcium indicators [104], [105]. The typical structure of a fluorescent 
dye consists of two moieties: a receptor responsible for the molecular recognition 
of the analyte, and a fluorophore, which signals the recognition event [106].  
Although the importance of Mg2+ is now widely acknowledged, for the past five 
decades, all the efforts in developing fluorescent probes have been made to study 
and monitor Ca2+ concentration in vivo, as a fast-acting principal second messenger. 
Therefore, Mg2+ has become the “forgotten cation” and the first Mg2+ indicators were 
simply derived from Ca2+ probes [92].  
Indeed, these first probes exploited the property of APTRA (-aminophenol-N,N,-
triacetic acid) and its fluorinated derivatives, which are structural analogues of the 
Mg2+ chelator EDTA (ethylenediaminetetraacetic acid) [107]. The APTRA structure 
was then modified around the furan ring, resulting in the fluorescent indicator 
FURAPTRA (mag-fura-2) which is still used in many laboratories [11]. 
Since then, many other dyes selective for Mg2+ have been synthesized, and most of 
them are analogues to the corresponding Ca2+ probes such as, mag-fura-2 
(FURAPTRA, analogue of fura-2), mag-indo-1 (analogue of indo-1), mag-fluo-4 
(analogue of fluo-4) and magnesium green (analogue of calcium green). 
These are the commercial dyes most widely used in tracking and quantifying the 
intracellular ion Mg concentration. However, they are all characterized by Kd(Mg2+) 
values in the millimolar range: therefore, they are suitable to detect mainly cytosolic 
magnesium ions (only 5% of the total) without providing any information about the 
bound pool. In addition, since they are derived from Ca2+-specific probes, they retain 
a considerable affinity for this ion and massive changes in Ca2+ concentrations may 
interfere with Mg2+ assessment.  
 
 
 
 2.4 Last generation fluorescent probes 
The limitations of the commercial probes mentioned above prompted the scientific 
community to develop new magnesium fluorescent indicators exploitable in live 
cells, which has resulted in the synthesis of several novel dyes with improved 
characteristics such as more affinity, selectivity and specificity towards Mg [92]. 
2.4.1 The KMG series 
The need to optimized magnesium sensors, especially in terms of binding affinity, 
led to the synthesis of KMG derivatives. The molecular design of these compounds 
is based on a charged -diketone binding site and a coumarin fluorophore that has 
a strongly improved magnesium selectivity. The first molecule of the series, KMG-
20 [108], achieved better selectivity for Mg2+ (kd 10 mM) in comparison to 
commercial probes, but the choice of a coumarin as chromophore provide an 
excitation in the UV region which prevent the excitation by the Ar+ laser commonly 
used with a confocal microscope [103]. KMG-104, which has a fluorescein 
chromophore, is an up-to-date version of the KMG series of magnesium probes, with 
improved properties and a Kd for Mg2+ of 2.1 mM [109]. KMG-104 can be excited in 
the visible range and its selectivity for Mg2+ over Ca2+ is much better than that 
displayed by commercial probes, rendering these dyes completely insensitive to 
physiological changes in cytosolic Ca2+ concentration. Moreover, KMG-104 was used 
to detect cytosolic Mg2+ accumulation upon mitochondria depolarization, which led 
to the hypothesis that mitochondria could be intracellular magnesium stores [109]. 
These characteristics make KMG-104 one of the most promising alternatives to 
detect free Mg2+ by live cell imaging.  
Another member of the family is the molecule KMG-301, an Mg2+-selective 
fluorescent probe that is functional in mitochondria. It is composed by a rhodamine 
skeleton as the chromophore and by a charged--diketone moiety as the binding site 
for Mg2+. Indeed, this probe changes its fluorescence properties solely depending on 
the Mg2+ concentration in mitochondria under physiological condition [110]. 
Moreover, combining measurements of KMG-301 together with KMG-104, the 
derivatives specific for cytosolic Mg2+, it make possible the comparison of the Mg2+ 
 dynamics in the cytosol and in mitochondria under mitochondrial uncoupling 
conditions in PC12 cells (rat pheochromocytoma of the adrenal medulla) and in 
hippocampal neurons [110]. 
 
More recently another very promising Mg2+ selective fluorescent probe, KMG-104-
AsH [111] was developed by combining the dye KMG-104 [112] and the fluorescent 
probe for protein-labeling, “FlAsH” that fluoresces only when it binds specifically to 
a TC-tag peptide genetically added to target proteins. KMG-104-AsH only becomes 
fluorescent when binding to both the TC-tag and Mg2+. Application of the probe for 
imaging of Mg2+ in HeLa cells showed that this KMG-104-AsH is membrane-
permeable and binds specifically to tag proteins, such as TCtag-actin and mKeima-
TCtag targeted to the cytoplasm and the mitochondrial intermembrane space. 
Therefore, this probe was shown to be useful for localized molecular imaging of 
changes in Mg2+ concentration and hence for elucidating the dynamics and 
mechanisms of intracellular localization of Mg2+ [111]. 
2.4.2 KCM-1 
KCM-1 is a novel single-molecular multianalyte sensor which permitted the 
simultaneous imaging of intracellular Ca2+ and Mg2+ in a cell [112]. The new dye 
combines in a single molecule a coumarin moiety as a stable fluorophore excitable 
with visible light, BAPTA as the Ca2+-selective binding site and a charged -diketone 
as the Mg2+-selective binding site. As a consequence, fluorescence emission of KCM-
1 shows a spectral blue shift upon complexation to Ca2+ and a red shift in the 
presence of Mg2+. The use of a single probe that allows the sensing of multiple 
analytes with different spectral responses is a promising way to overcome the 
difficulties encountered when loading multiple indicators. Despite the novelty 
represented by a single-molecular multianalyte sensor, the binding characteristics 
of KCM-1 are quite inadequate, since the Kd values for Ca2+ and Mg2+ are reported to 
be 14 µM and 26 mM respectively, which are definitely too high to actually measure 
the intracellular concentrations of these ions. However, KCM-1 has been capable to 
detect distinct Ca2+ and Mg2+ transients upon mitochondrial depolarization [112]. 
 
 2.4.3 AMg1 e AMg1-AM 
AMg1 is a novel Mg indicator specifically designed for two-photon microscopy.  
AMg1 was designed with 2-acetyl-6-(dimethylamino)naphthalene as the two-
photon chromophore and APTRA as the Mg2+-selective binding site [113].  
To enhance the cell permeability of the probe, the carboxylic acid moieties were 
converted into acetoxymethyl (AM) esters (AMg1-AM).   
Moreover, increasing the polarity of the solvent, the esterified form of the probe 
(AMg1-AM) presents an high shift of fluorescence toward red, which allows to 
discriminate between the cytosolic hydrolysed form of the probe (red fluorescence) 
and the membrane-associated form (blue fluorescence). 
This characteristic should allow to discriminate the contribution of membrane-
bound probe, and thus eliminate a source of error in Mg2+ quantification [113].  
 
2.4.4 The DCHQs series 
Despite the growing interest in the synthesis of new and more specific 
chemosensors for magnesium, all the last generation fluorescent probes mentioned 
above still have a Kd(Mg2+) in the millimolar range. The lack of selective and specific 
compounds for total magnesium currently represents a technical limitation in the 
study of intracellular content and distribution of this cation [114]. Indeed, a large 
body of experimental evidence documenting the occurrence of large fluxes of Mg2+ 
across the cell membrane in response to a variety of hormonal and metabolic 
stimuli, attended by considerable changes in plasma Mg2+ levels [15]. These fluxes, 
however, have resulted in relatively small changes in free Mg2+ intracellular 
concentration, even though significant changes in total Mg content within cells have 
been observed [91]. 
This suggest that the amount of free Mg2+ is kept constant at the level necessary for 
cellular metabolic demands by the ability of the cell to rapidly buffering modification 
of the free fraction, suggesting that modification of magnesium availability are 
accomplished by changes in the distribution (binding) of magnesium among cellular 
subcompartments [76], [12]. In this perspective, a tool able to detect and/or 
 discriminate between free and total magnesium and between Mg2+ content of 
cytosolic and intracellular subcompartments would be particularly useful [115].  
 
8-Hydroxyquinoline (8-HQ), is considered as the second Mg2+ chelating agent in 
importance after EDTA [116]. 8-HQ is mostly non-fluorescent in aqueous or organic 
solutions and undergoes a fluorescence enhancement upon cation binding, which 
results in an intense yellow-green signal. Furthermore, the fluorescence of the 
complex species depends on the environment and becomes higher as lipophilicity 
increases [117], [118]. The selectivity of 8-HQ is poor, but it can be improved by 
appropriate substitution. In this context, particular interest has gained a new family 
of fluorescent molecules obtained by conjugation of a diaza-18-crown-16 with two 
8-hydroxyquinolines bearing various substituents (DCHQs) (Fig 2.1) [92]. 
 
 
Figure 2.1: Chemical structure of the DCHQ-based probes 
 
These molecules have been proposed as effective chemosensors for different ions; 
in particular, some members demonstrated high specificity for Mg2+, with an 
excitation wavelength around 363 nm and an emission wavelength centered around 
505 nm. 
DCHQ1, the first member of the family, binds Mg2+ with much higher affinity than 
any other available probe (Kd = 44 µM) and shows a strong fluorescence increase 
upon complexation. Remarkably, its fluorescence is not significantly affected either 
by other divalent cations, most importantly Ca2+, or by pH changes within the 
physiological range [29] [33]. It is worth noting that DCHQ-based compounds 
proved to be a valuable tool to detect total cell magnesium, due to their Kd in the 
 micromolar range, that is the same order of magnitude as (and hence able to 
compete with) ATP, which is the major intracellular Mg2+ ligand [114], [120]. 
Moreover, DCHQ1 readily permeates cells, binds intracellular Mg2+, and it has been 
employed to map intracellular ion distribution and movements in live cells by 
confocal imaging [114], [115].  
Furthermore, this probe has been shown to be a suitable analytical tool capable to 
quantitatively assess the total intracellular magnesium in different cell lines [120]. 
The evaluations of cell total magnesium by DCHQ1 fluorescence in leukemic (HL60) 
and mammary epithelial (HC11) cells resulted in a three to fourfold overestimation 
compared to magnesium measured by AAS. The hydrophobic nature of DCHQ1 and 
the lifetime measurements performed by single-photon counting 
spectrofluorometry, suggested that the enhancement obtained in intact cells could 
be due to the entrapment of the probe in membrane compartments [115]. Indeed, it 
has been described that hydrophobic derivatives of hydroxyquinoline preferentially 
distribute into lipophilic moieties [121]. Farruggia et al. showed that upon 
disruption of cells by sonication, DCHQ1 fluorescence substantially decreases, 
obtaining overlapping results with AAS by using a simple spectrofluorimetric assay 
[115] [120].  
Besides the unquestionably analytical value of DCHQ1, some limitations of this 
probe, such as its poor intracellular retention and the fact that it can be exited only 
in the UV region, have restricted its application for monitoring magnesium 
movements across intracellular compartments. Farruggia et al. developed a new 
method for the chemical synthesis of DCHQ compounds based on microwave 
heating, in order to reduce the reaction time, to increase the yield and to minimize 
the side reactions. This approach ultimately results in much easier purifications and 
higher quality products compared to the classic synthetic approach [122]. 
Moreover, the new protocol has permitted to easily modify the basic structure of 
DCHQ1 by introducing various functional groups in position 2, 4 or 5 of the 
quinolone ring system [122]. New compounds were designed to overcome the 
aforementioned limitations of the parent probe and to improve fluorescence 
response upon cation binding, uptake and intracellular localization preventing the 
unique feature of selectively binding total intracellular magnesium [114]. Among 
 the panel of the DCHQ derivatives, particularly interesting features were observed 
for the derivative bearing a phenyl group as a substituent in position 5’ of each 
hydroxyquinoline arm, named DCHQ5 (Fig. 2.2). 
 
Figure 2.2: Chemical structure of the DCHQ5 
 
In fact this probe presents improved characteristics compared to DCHQ1 such as 
higher fluorescence, membrane staining, a much higher retention within loaded 
cells and the possibility to avoid the UV excitation, which could be potentially 
cytotoxic, as DCHQ5 could be exited both in the UV and visible spectrum range [114].  
For all these peculiar features, DCHQ5 appears to be a valuable candidate to shed 
new light on magnesium homeostasis at the cellular level.  
 
2.4.5 MagFRET 
 
Last development in the field of fluorescence chemosensors is referred to the 
genetically encoded metal sensors based on the Förster Resonance Energy Transfer 
(FRET). Indeed, genetically encoded fluorescent sensor proteins provide an 
attractive alternative to small-molecule fluorescent sensors, because they do not 
require cell-invasive procedures, their concentration can be tightly controlled and 
they can be targeted to different locations in the cell [123].  
MagFRET-1 is the first genetically encoded fluorescent magnesium sensor with a Kd 
for Mg2+ of 148 µM, and it shows a 50% increase in emission ratio upon Mg2+ binding 
[124]. A general advantage of genetically encoded sensors is that their subcellular 
localization can be easily controlled, and in situ experiments in HEK293 cells 
showed that MagFRET-1 could be targeted to the cytosol and the nucleus. As regard 
 the limitation of MagFRET-1, although it is responsive to changes in Mg2+ 
concentration in permeabilized cells, for some unknown reason MagFRET-1 is less 
responsive in intact cells. Moreover, MagFRET-1 responds to changes in Mg2+ 
concentration in the order of seconds both in vitro and in cells, but as the other 
protein-based sensors, it displays slower kinetics than small molecule sensors and 
for this reason, it is not able to detect extremely fast Mg2+ movements. In addition, 
MagFRET-1 miss sensitivity for changing in overall Mg2+ levels over longer periods 
of time [124].  
 
2.5 X-Ray microscopy 
In recent years, growing interest has been given to single cells analysis for 
investigating the smallest dimensions of living systems. 
The requirement of elemental analysis in biological system is a challenging issue for 
defining the intracellular concentration map of a given element. Indeed, the 
biological function of a chemical element in cells does not only require the 
determination of its intracellular quantity, but also the spatial distribution of its 
concentration, since the different localization of a specific element within a cell often 
refers to a different biological function.  
Moreover, many basic aspects and regulatory mechanisms of cell functions are 
related to the intracellular compartmentalization of the ions whose different 
gradient concentrations generate the driving force of many cellular processes [125]. 
Further insights into biological processes and cellular analysis require quantitative 
techniques, mainly nondestructive with high elemental and chemical sensitivity and 
high spatial resolution. Nowadays, several quantification techniques, based on 
electron, photon, and synchrotron X-ray and ion, allow to obtain the elemental and 
chemical imaging of single cells [126].  
Among these, X-Ray microscopy based on synchrotron light source has gained 
increasing attention in the last years thanks to its extreme sensitivity and to the 
improvements that have been achieved in third-generation Synchrotron X-ray 
sources and in X-ray focusing optics. In particular, X-ray Fluorescence Microscopy 
(XRFM) is a highly sensitive method for mapping elements distribution in single 
 cells at nanoscale resolution [127]. However, when applied to whole cells, the 
fluorescence intensity map obtained with XRFM can be misleading because it gives 
information on the total element content and not on element concentration, as the 
probed volume is not known [128]. Indeed, biological samples are by definition 
heterogeneous in density and thickness; therefore, in order to be quantitative, XRFM 
must be complemented with other imaging techniques able to provide detailed 
density and volumetric intracellular distribution [126].  
Towards this end, extremely interesting is a new methodology for quantitative 
mapping of light elements in cells, based on combination of compositional and 
morphological information, derived respectively by X-ray Fluorescence Microscopy 
(XRFM), Atomic Force Microscopy (AFM) and Scanning Transmission X-ray 
Microscopy (STXM) [125]. In particular, authors shown that the combination of AFM 
with STXM allows to retrieve the intracellular density. Thus, combining the density 
obtained with STXM and AFM to the fluorescence intensity map derived by XRFM, it 
is possible to obtain high resolution molar concentration and mass fraction maps of 
fundamental life elements (Carbon, Nitrogen, Oxygen) as well as light metals, in 
particular Mg [125]. By using the principles of this technique, a new developed 
method allows to address Magnesium in subcellular compartments. 
 
  
  
 3 AIMS 
Although the biological relevance of magnesium is now widely recognized, a full 
understanding of cellular magnesium homeostasis and the mechanisms regulating 
its distribution and intracellular compartmentalization have not been achieved. This 
can partly be attributed to the lacking of available techniques and methodologies 
able to rapidly and accurately measure changes in intracellular Mg content [92]. 
Mammalian cells tightly regulate magnesium ion content through specific 
mechanisms controlling Mg2+ entry and efflux across plasma membrane and other 
membrane of sub-cellular organelles [91]. Indeed, magnesium buffering within the 
cytoplasm at concentration in the sub-millimolar range implies that Mg2+ 
fluctuations could only be traced by techniques able to sense minor changes [92]. 
Moreover, free and total magnesium undergo different and independent regulatory 
mechanisms, and it is reported that modifications of magnesium availability 
biologically relevant are accompanied by major changes in total Mg content, while 
the free fraction is well buffered, indicating that rearrangements took place in the 
distributions of bound magnesium among cellular ligands and/or sub-
compartments [12], [76].  
In this perspective, notably appealing are the members of the fluorescent dyes 
diaza-crown-hydroxyquinoline family which demonstrated high specificity for Mg2+ 
having a Kd in the micromolar range [115] making these probes able to detect total 
intracellular magnesium. 
Among these, particularly interesting features were observed for the phenyl 
derivative of these family (DCHQ5) that showed high response to cation binding, 
membrane staining, high intracellular retention and the possibility to be excited 
both in the UV and visible spectrum range [114].  
Taking into account the peculiar properties of DCHQ5, in the first part of the project 
we investigated the analytical capabilities of this fluorescent probe for the 
quantitative assessment of total intracellular magnesium content and its biological 
applications. To accomplish this task, we performed a comparative study of DCHQ5 
and DCHQ1, the latter being the mother probe of the series which showed 
preliminary encouraging results comparable to atomic absorption spectroscopy 
[120]. We performed fluorescence spectroscopy assays to evaluate the fluorescence 
 intensity and stability of the two probes, and also flow cytometry analyses in viable 
cells to test intracellular retention of DCHQ1 and DCHQ5, as well their fluorescence 
stability over time. Moreover, we deeply investigate the analytical performances of 
the probes for the quantitative assessment of the intracellular total magnesium by 
using a new spectrofluorimetric protocol based on a standard titration curve in 
sonicated cellular samples. For these analyses we used AAS as gold standard, and 
we also estimated the sensitivity of our method by the evaluation of the limit of 
detection. 
The unique feature of DCHQ5 to be excitable in the visible region renders this dye 
very interesting for fluorescence lifetime imaging (FLIM) applications. In fact, this 
property allows to minimize the background interference coming from the cell auto-
fluorescence. In addition, a common characteristic of the members of the DCHQ 
family is to show a bi-exponential fluorescence lifetime decay in the intracellular 
environment [115]. Therefore, we also performed FLIM measurements in 
collaboration with the group of Professor Paola Taroni at the Politecnico of Milan to 
explore the capability of DCHQ5 to obtain FLIM image of intracellular Mg which has 
never been done so far. 
Moreover, DCHQ5 was also exploited for studying the involvement of magnesium in 
the commitment of human adipose-derived mesenchymal stem cells (hASCs) with a 
mixture of hyaluronic, butyric and retinoic (HBR) acids, in collaboration with the 
research group of Professor Carlo Ventura. In particular we monitored the 
intracellular total magnesium content of hASCs cultured in complete and also in Mg-
free medium. In parallel, we also performed cell cycle analysis and we examined the 
gene expression of a panel of markers representing the multilineage potential of 
these cells. Finally, the gene expression was assessed again after the re-addition of 
Mg to the deprived medium to further investigate the possible Mg modulation on 
gene expression. 
 
The second part of this research was aimed at comparing single cells elemental 
analysis performed with synchrotron-based fluorescence and cell population 
analysis carry out by DCHQ5. In particular, we investigated the pitfalls and 
advantages of the two different strategies for the quantification of intracellular Mg 
 in three cellular models: human colon carcinoma cells sensitive (LoVo S) and 
resistant (LoVo R) to doxorubicin, endothelial cells isolated from the umbilical vein 
(HUVEC) wild type and genetically engineered to silence TRPM7, and human SaOS2 
bone osteosarcoma cells cultured in standard and Mg-deprived conditions. 
We exploited a standard-less approach providing a complete characterization of 
whole single-cells by combining X-Ray Fluorescence Microscopy (XRFM), Atomic 
Force Microscopy (AFM) and Scanning Transmission X-ray Microscopy (STXM). This 
method allows the quantification of the intracellular spatial distribution and total 
concentration of magnesium and other light elements (C, O, N) in whole dehydrated 
cells [125]. Subsequently, we quantified the total amount of intracellular Mg2+ in a 
large population of the same samples by using DCHQ5 probe and 
spectrofluorimetric technique, aimed to compare the data obtained in small groups 
of dehydrated cells with ones of a large cell population. Moreover, the data obtained 
by synchrotron-based single cell analysis where normalized for the volume of the 
corresponding population to further compare the concentration calculated in single 
cells analysis with the concentration calculated using DCHQ5.  
    
 4 MATHERIALS AND METHODS 
PART I 
4.1 Reagents 
All reagents were from Sigma Aldrich (Italy), if not differently stated, and were of 
ultrapure grade. Dulbecco’s Phosphate-Buffer Saline (DPBS) was purchased without 
Ca2+ and Mg2+. The fluorescent probes were dissolved in dimethyl sulfoxide (DMSO) 
to a final concentration of 1 mg mL-1 (DCHQ1 1.7 mM, DCHQ5 1.4 mM). Aliquots were 
kept at 4°C in the dark. 
Fetal bovine serum (FBS) was stripped of Mg by dialysis, using a dialysis membrane 
(Medicell International LTD, UK) with a 3500 D cut-off against Puck buffer (NaCl 800 
g/L, KCl 4 g/L, NaHCO3 3.5 g/L, D-glucose anhydrous 5 g/L, pH 7.4) plus EDTA 1mM 
for two days, and Puck buffer alone for the last three days. The Ca content in dialysed 
FBS was restored by adding CaCl2 at a final concentration 1.8 mM. The FBS was then 
sterilized by filtering through a 0.45 µm filter. 
Mg-free MEM was purchased from Invitrogen (San Giuliano M.se, Italy). To 
reconstitute the full magnesium medium content MgCl2 1 mM was added. 
4.2 Cell culture  
All the following cell lines (human HL60 Promyelocytic Leukemia, human HT29 
colon adenocarcinoma, human LoVo colon adenocarcinoma, human U2OS and 
SaOS2 osteosarcoma) were grown at 37°C and 5% CO2 in RPMI 1640 medium, 
supplemented with 2 mM L-Glutamine, 10% heat-inactivated fetal bovine serum 
(FBS), 100 units mL-1 penicillin and 100 µg mL-1 streptomycin.  
 
4.2.1 Adipose- derived stem cell isolation 
According to the policy approved by the local ethical committee, all tissue samples 
were obtained after informed consent from healthy donors. Human subcutaneous 
adipose tissue samples were obtained from lipoaspiration/liposuction procedures 
from several regions of the body, such as hip, thigh and abdominal regions, and 
 collected into a sterile container. After washing, lipoaspirates were digested with 
0.2% collagenase A type I solution (Sigma-Aldrich), under gentle agitation for 45 
min at 37°C, and centrifuged at 650 g for 10 min to separate the stromal vascular 
fraction (SVF) from adipocytes. If necessary, the SVF fraction was treated with red 
blood cell lysis buffer for 5 min, and then centrifuged again. The supernatant was 
discarded and the cell pellet was resuspended and seeded in culture flasks in 
Minimum Essential Medium Eagle - Alpha Modification (α-MEM, Lonza) 
supplemented with 20% heat-inactivated fetal bovine serum (FBS), 1% penicillin-
streptomycin, 2 mM L-glutamine, and incubated at 37°C in a humidified atmosphere 
with 5% CO2. When the cultures were near confluence, the cells were detached by 
treatment with trypsin-EDTA solution (Sigma-Aldrich), characterized, subcultured, 
and used at passage 3-6. 
 
4.2.2 Adipose- derived stem cell treatment 
Twenty-four hours after seeding in α-MEM 10% FBS, cells were cultured in absence 
(Ctr) or presence (HBR) of a mixture of hyaluronic (1 mg/ml), butyric (5 mM) and 
retinoic acid (1 µM), referred as HBR. The day of treatment is considered time 0 of 
analysis. The culture basal medium of all experiments was the Mg-free MEM 
(Invitrogen) for studying the effect of Mg deprivation to hASCs commitment 
(referred as -Mg). For the experiment in presence of normal Mg concentrations, the 
Mg-free MEM medium was supplemented with MgCl2 1mM.  
For Mg-free media, dialysed FBS was used.  
4.3 Photophysical measurements 
Absorption spectra were recorded on a Perkin-Elmer Lambda 45 
spectrophotometer. Absorption spectra of DCHQ1 25µM were acquired in two 
different buffer: MeOH:MOPS (methanol:H2O 1:1 buffered at pH 7.4 with 3-
morpholinopropane-1-sulfonic acid at room temperature) and DPBS upon addition 
of increasing amount of MgSO4 (from 0 to 500 µM). Absorption spectra of DCHQ5 10 
µM were acquired in MeOH:MOPS. 
 For the fluorescence spectroscopy measurement, uncorrected emission and 
corrected excitation spectra were obtained with a PTI Quanta Master C60/2000 
spectrofluorimeter (Photon Technology International, Inc., NJ, USA). 
4.4 Titration of Mg2+ binding by fluorescence spectroscopy 
Increasing amount of a 100 mM solution of MgSO4 were added to a 25 µM solution 
of DCHQ1, in two different buffer (DPBS and MeOH:MOPS), and to a 10 µM solution 
of DCHQ5 in MeOH:MOPS, to obtain Mg2+ concentration from 0 to 500 µM. 
Fluorescence spectra were recorded, upon excitation at 360 nm, in the range from 
400 to 650 nm. 
4.5 Stability of the probes 
For the determination of the stability of the probes, the emission wavelength was 
set to the value of the maximum (500 nm for DCHQ1 and 510 nm for DCHQ5) and 
the samples were excited continuously for 30 minutes. Spectra were acquired at two 
different concentrations of magnesium, chosen to test a Mg:dye ratio of 1:2 and 
100:1. 
4.6 Quantification of total cell magnesium by AAS 
Total magnesium content was assessed by AAS on acidic cellular extracts of a sample 
of 1-2 x 106 cells/mL. Harvested cells were washed twice in cold DPBS by 
centrifugation and then pelleted at 250 g. Ion extractions were obtained by 
overnight treatments of the cell pellets with 3 mL of 1.0 N HNO3. After agitation and 
centrifugation of samples, magnesium was assayed on cell supernatants by AAS 
(Instrumentation Laboratory mod. S11, USA or Perkin Elmer AA200) equipped with 
an air/acetylene flame. 
4.7 Quantification of total cell magnesium by a 
spectrofluorimetric assay 
Total magnesium content was assessed on sonicated cell samples by the two 
fluorescent dye DCHQ1 and DCHQ5 choosing a method that involves the 
 construction of a standard curve. Briefly, DCHQ5 was dissolved to a final 
concentration of 15 µM in a mixture which contains 10% of DPBS in a solution 1:1 
of MeOH:MOPS 2 mM (pH 7.4), while DCHQ1 was dissolved to a final concentration 
of 25 µM in DPBS. Different amounts of MgSO4 were added and the fluorescence 
intensities were acquired at 510 nm for DCHQ5 and at 500 nm for DCHQ1. The Mg 
concentration of the unknown samples were obtained by the interpolation of their 
fluorescence with the standard curve.  
The same protocol was also adopted for hASCs to assess the Mg concentration by 
DCHQ5.  
4.8 Limit of detection 
The determination of the limit of detection (LOD) was performed using the following 
protocol: we prepared three different solutions each containing the same and 
known amount of Mg ions and we did this for three different increasing amounts of 
the analyte, always with a fixed chemosensor concentration. For each concentration 
we registered the fluorescence emission spectra, and we calculated the mean value 
of emission intensity in the maximum of the band (arithmetic mean). We did the 
same for all the different concentrations of Mg2+ and the results were plotted as a 
function of the metal ion concentration. After performing a linear regression of this 
curve, we calculated the standard deviation σx of the lowest concentration 
according to the following equation: 
 
σx = √
∑ (xi − x̅)2
N
i=1
N − 1
 
 
The concentration value corresponding to an intensity of + 3σx was taken as the LOD 
of our system. The LOD was performed for both the two probe in the assay buffer 
(MeOH:MOPS+10% of DPBS for DCHQ5 and DPBS for DCHQ1) and in sonicated 
cellular samples. 
The detection limit for Mg in AAS was established by analysis of >10 blank solutions 
(LOD 3xSD); blank value was 20±3 ng/ml, so the detection limit resulted 6 ng/mL 
 (0.2 µM). Trace metals standard (MA-M-2/TM: lyophilized mussels) were analyzed 
every 20 samples and all values measured for reference materials were within 
certified limits given by the IAEA (International Atomic Energy Agency).  
4.9 Flow cytometry 
Flow cytometric measurements were performed on a Bryte HS cytometer (BioRad, 
UK), equipped with a Xe-Hg lamp, using a filter set with an excitation band centered 
at 360 nm and two emission bands centered respectively at 500 nm (for the DCHQ 
derivatives fluorescence) and 600 nm (for the propidium iodide fluorescence). 
Before the staining, cells were detached with 0.11% trypsin, 0.02% EDTA, washed 
twice in DPBS and suspended at a final concentration of 5 x 105 cells/mL. The cells 
were incubated for 15 minutes in the dark at 37°C with DCHQ5 5 μM and DCHQ1 25 
µM respectively and then analyzed. Each cell sample was counterstained with 5 µg 
mL-1 propidium iodide (PI) to identify dead cells. Fluorescence distributions were 
recorded using a logarithmic scale. To assess the intracellular trapping of the dyes, 
the stained samples were washed in DPBS and reassayed by flow cytometry. 
4.10 Cell cycle analysis 
Human adipose-derived mesenchymal stem cells were detached with 0.11% 
trypsin, 0.02% EDTA, washed twice in DPBS and centrifuged. The pellet was 
suspended in 0.01% nonidet P-40, 10 mg/mL RNase, 0.1% sodium citrate and 50 
μg/mL propidium iodide (PI), for 30 min at room temperature in the dark. 
Propidium iodide fluorescence was analyzed using a Bryte HS flow cytometer 
(Biorad,UK) equipped with Hg lamp and analyzed with ModFit (Verity Software 
House, USA) software. 
4.11 Gene expression in hASCs 
Total RNA from control or treated cells was extracted at 5-10 days using the RNeasy 
Mini Kit (QIAGEN) according to the manufacturer’s instructions, and quantified 
using Nanodrop. One μg of RNA from each sample was reverse-transcribed into 
cDNA in a 20-μl reaction volume with SuperScriptTM III reverse transcriptase 
 (Invitrogen). To assess gene expression of a panel of markers, 2 μl of cDNA were 
used for real-time PCR performed with a Lightcycler system (Roche Applied 
Science) and with the GoTaq® qPCR Master Mix (Promega), following the 
manufacturer’s instructions for Fast Cycling Program.  
Primers used (0.25 μM) were as follows:  
GAPDH: forward 5’-CAGCCTCAAGATCATCAGCA-3’ and reverse 5’-
TGTGGTCATGAGTCCTTCCA-3’; 
GATA-4: forward 5’-ACCACAGCACAGCCTCATC-3’ and reverse 5’-
CAGAGCGGGAAGAGGGATTT-3’; 
HGF: forward 5’-ATTTGGCCATGAATTTGACCT-3’ and reverse 5’-
ACTCCAGGGCTGACATTTGAT-3’;  
KDR: forward 5’-CTGCAAATTTGGAAACCTGTC-3’ and reverse 5’-
GAGCTCTGGCTACTGGTGATG-3’; 
NANOG: forward 5’-CCTTCCTCCATGGATCTGCTT-3’ and reverse 5’-
CTTGACCGGGACCTTGTCTTC-3’;  
NEUROG: forward 5’-CCGCCTTGAGACCTGCATC-3’ and reverse 5’-
GGCTGCCTGTTGGAGTCTG-3’; 
NKX-2.5: forward 5’-GCACCCACCCGTATTTATGT-3’ and reverse 5’-
GGGTCAACGCACTCTCTTTAA-3’. 
Data were normalized using GAPDH as an index of cDNA content after reverse 
transcription. Samples were run in duplicate, and the average threshold cycle (Ct) 
value was used for calculations. Relative quantification of mRNA expression was 
calculated with the comparative Ct method using the “delta-delta method” for 
comparing relative expression results between treatments in real-time PCR [129].  
4.12 Fluorescence lifetime imaging (FLIM) 
For the fluorescence lifetime imaging measurements, LoVo S cells were seeded in a 
glass dish at the concentration of 1 x 105 cells/cm3 for 24h. 
Before the analyses, cells were washed twice with DPBS without Ca2+ and Mg2+ and 
directly incubate in the dish with DCHQ5 5µM in the dark for 15 minutes. 
 The Fluorescence Lifetime Imaging Microscopy (FLIM) experiments were done 
using a wide field microscope (Leica DM R) in epifluorescence configuration, 
coupled to a fast gated ICCD camera. The excitation light was provided by a 
supercontinuum laser source based on a photonics crystal fibre (SuperK EXTREME 
- NKT photonics, Denmark). The laser is made by two Ytterbium (Yb) doped optical 
fibres, in the master oscillator/power amplifier configuration, which emits 10 ps 
pulses at 1080 nm, with a repetition rate selectable from 10 to 40 MHz. The laser 
light is then processed by a photonics crystal fiber that transforms the narrowband 
Yb radiation, through non-linear effects, into white light pulses extending from 400 
nm to 2400 nm. For the FLIM experiments the repetition rate was set to 20 MHz and 
an acousto-optic modulator was used to select a 10 nm wide portion of the white 
spectrum centred around 485 nm. The laser light was then coupled to a large core 
optical fibre (400 μm), whose distal end was imaged through a homemade optical 
system into the focal plane of the microscope, in such a way that the same region of 
the field of view (about 2/3 of the diameter) was uniformly illuminated using 
whatsoever objective. The discrimination of the fluorescence emission from the 
laser light was achieved thought a dichroic mirror at 505 nm and a high pass 
emission filter, with a cut-on wavelength of 500 nm, was employed to remove the 
residual excitation light. 
The detection system was based on a fast light intensifier that can be gated from 200 
ps to 1 ns, synchronously with the laser pulses. The intensifier is coupled to a low-
noise, cooled CCD camera by means of a high-aperture lens (Picostar, LaVision 
GmbH, Göttingen, Germany). The light intensifier is synchronised with the laser 
pulses by a trigger unit made by a fast photodiode coupled to a constant-fraction 
discriminator and by a jitter free delay generator capable of delays from 0 to 22 ns 
in 25-ps steps. The jitter of the overall system has been estimated to be less than 50 
ps. The whole apparatus is computer controlled by means of software that 
automatically sets the acquisition parameters (delay, gain of the light intensifier, 
etc.) and takes the sequence of the gated images. 
For the selection of the field of view a 10X objective was used, while all the 
fluorescence measurements were done with a 63X, 0.9 NA water immersion 
objective (Leica HCX APO). The optical power in the image plane was 300 μW, 
 corresponding to a power density of about 15 mW/cm2, with the 63X objective. The 
gate width of the light intensifier was set to 1 ns and, for each field of view, a 
sequence of images was acquired with delays of 0, 1, 2, 3, 4, 5, 7, 9, 11, 13, 15, 20 
nanoseconds, with respect to the excitation pulses. 
The data analysis was done using a custom written software based on the Matlab 
engine. In each image set, an Area Of Interest (AOI) was selected by visual inspection 
in order to isolate a discrete number of cells (usually from 1 to 3). Then, the dataset 
made by the AOIs of all the gated images was processed using a parallel fitting 
algorithm working, pixel by pixel, with a modified bi- exponential model function. 
 
F is the fluorescence, i.e. the integral of the fluorescence intensity within the gate 
time, d is the acquisition delay for each image of the sequence, A1, A2, τ1 and τ1 are 
the amplitude and lifetime of the two fluorescence components, respectively, the 
Offset has been introduced to account for any background noise and the terms [1- 
exp (-Gate/τ)] are required to correct for the finite width of the sampling window. 
The fitting method is based on a standard least mean square algorithm, with initial 
conditions randomly varied within proper intervals to avoid the convergence of the 
algorithm toward local minima. 
Finally the maps of the parameters A1, A2, τ1 and τ1 are plotted in false colours with 
a uniform colorbar. 
 
 
 
 
 
 
 
 
 
 
 PART II 
 
4.13 Cell culture and reagents 
For the comparative analyses of intracellular magnesium in single cells and in a large 
cell population by atomic force microscopy and X-ray measurements vs DCHQ5, 
three cellular models (human colon carcinoma cells (LoVo), human endothelial cells 
isolated from the umbilical vein (HUVEC) and human bone osteosarcoma cells 
(SaOS2)) were adopted, and variously treated to obtain samples with differences in 
total Mg content.  
Below, are reported the specific protocols adopted for each cell line. 
Human colon carcinoma cells LoVo, sensitive (LoVo-S) and resistant (LoVo-R) to 
doxorubicin were cultured in RPMI 1640, supplemented with 10% FBS, 2 mM 
glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin sulfate. To keep 
the cells resistance to doxorubicin, LoVo-R cell line were fed once every 2 weeks 
with 1 μg/mL doxorubicin. 
Cells were seeded at the concentration of 1 × 104 cell/cm2 and incubated at 37 °C in 
5% CO2 for 24 h before the analyses. 
HUVEC were isolated from the umbilical vein and cultured in M199 containing 10% 
FBS, 1 mM glutamine, 1000 units/mL penicillin and 1 mg/mL streptomycin, 
endothelial cell growth factor (ECGF) 150 µg/mL, 1 mM sodium pyruvate and 
heparin (5 units/mL).  To evaluate the effect of TRPM7 silencing on magnesium 
content, a Tet on/Tet off system was used to silence TRPM7 (sample were named 
+Doxy) after the exposure of the cells to Doxycicline (2ug/ml) for 48h.  
To synchronize SaOS2 cells and reduce intracellular magnesium, the cells were 
cultured for 24h in Mg-free MEM medium with 0.5 % of dialysed FBS. After 24h of 
Mg and serum deprivation, the cells were switched to a 5% FBS Mg free medium in 
the presence and absence of MgCl2 1 mM for 24h and then analyzed (the samples 
were respectively named +Mg and –Mg). 
For atomic force microscopy and X-ray measurements, all cells lines were plated at 
a concentration of 1 × 104 cell/cm2 on 1 × 1 mm2, 200-nm-thick silicon nitride 
 (Si3N4) membrane windows, mounted on a 5 × 5 mm2 Si frame (Silson) previously 
sterilized in ethanol. All cell line were treated as reported above, and at the specific 
times of analyses cells were rinsed with 100 mM ammonium acetate and cryofixed 
by plunge freezing in liquid ethane and then dehydrated in vacuum at low 
temperature overnight. 
4.14 Quantification of total cell magnesium by DCHQ5 
Total magnesium content was assessed on sonicated cell samples by using the 
fluorescent chemosensor DCHQ5 as reported in paragraph 4.7. 
The Mg concentrations of the unknown samples obtained by the interpolation of 
their fluorescence with the standard curve were normalized to the cell volume 
measured as described below in the paragraph 4.15. 
4.15 Determination of the cell volume 
All cells lines were detached by trypsinization, centrifuged and resuspended in DPBS 
at a final concentration ranging between 4000 cells/mL and 8000 cells/mL.  
Cells volumes were then calculated counting the cells on a double-threshold Z1 
Coulter Counter (Beckman Coulter, USA) and the thresholds were set to cover the 
interval from 268 to 5575 fL, each step corresponding to an increase of 1 μm in cell 
diameter. The mean cellular volume was estimated from the Gaussian distribution 
of the data. The analysis were carried out in triplicate. 
4.16 Fluorescence and Scanning Transmission X-Ray Microscopy 
analysis 
The X-Ray Fluorescence Microscopy (XRFM) and Scanning Transmission X-Ray 
Microscopy (STXM) measurements were carried out at the beamline Twinmic at 
Elettra Synchrotron (Trieste, Italy). A Fresnel zone plate focused the incoming beam 
(1475 eV), monochromatized by a plane grating monochromator, to a circular spot 
of about 600 nm in diameter. The sample was transversally scanned in the zone 
plate focus, in steps of 500 nm. At each step, the fluorescence radiation intensity was 
measured by eight Si-drift detectors (active area 30 mm2) concentrically mounted 
 at a 20° grazing angle with respect to the specimen plane, at a detector-to-specimen 
distance of 28 mm. Simultaneously, the transmitted intensity T was measured by a 
fast-readout electron-multiplying low-noise charge-coupled device (CCD) detector 
through an X-ray−visible light converting system. Zone plate, sample, and detectors 
were in vacuum, thus avoiding any absorption and scattering by air. 
Acquisition Protocol  
Dehydrated cells mounted on the Si3N4 membrane windows were carefully 
examined with optical microscope and selected following these criteria: integrity, 
dimensions (large cells require longer acquisition time), and distance from other 
cells (clustered cells have been avoided because AFM measurements require some 
free space around the cells). AFM measurements were performed on selected cells 
before XRFM and STXM measurements. Five STXM images were acquired on whole 
cells with a step size of 500 nm. In sequence XRFM, and simultaneously STXM, were 
carried out with a range of 6−8 s dwell time per pixel depending on the cell size. The 
total acquisition time was in the range of 5−8 h (field of view of at least 20 × 20 μm; 
spatial resolution 500 nm).  
Mass Fraction and Concentration Calculation  
To obtain quantitative information from the measurement of XRFM, we used the 
fundamental parameter method.  
The mass fraction maps (wp)i  of each elements  were calculated by the following 
expression: 
(𝒘𝒑)𝒊 =
(𝑹𝒑)𝒊
𝝆𝒑 ∙ 𝑽𝒑 × 𝒀(𝑬𝟎,𝒊) × 𝑭𝒑
 
 
 
where Vp is the volume of the pixel p, expressed in cm3, and Fp is the correction 
factor for the self absorption of both the incident beam and the fluorescence 
radiation. 
 
Analogously, the concentration (Mp)i, expressed in molarity, is derived by the 
following expression: 
  
 
 
where m is the mass expressed in grams, and Ai is the atomic weight of the element 
and V is the volume.  
 
 
 
Statistical Analysis 
Differences of each experimental condition were evaluated by Student's t test and 
set as following: *p<0.05, **p<0.01, ***p<0.001. 
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 5 RESULTS AND DISCUSSION 
 
PART I 
 
5.1 Study of the analytical capabilities of DCHQ5 for the 
quantitative assessment of total intracellular Mg content 
The first part of this study was focused on the analytical properties of the fluorescent 
chemosensor DCHQ5 for the quantitative assessment of the intracellular total 
magnesium content, and its biological applications. 
 
5.1.1 Photophysical Properties of DCHQ5 
We compared the analytical performance of DCHQ5 with the mother probe of the 
DCHQ family (DCHQ1), which so far was the only dye capable to quantitatively 
assess intracellular total Mg content [120]. 
As reported, DCHQ5 shows a significant increase in fluorescence intensity in the 
presence of Mg ions in MEOH:MOPS solution buffer, while it is not soluble in aqueous 
buffer, such as Dulbecco’s Phosphate Buffered saline (DPBS). On the contrary, 
DCHQ1 is also soluble in DPBS. 
Therefore, a more suitable comparison required the evaluation of the titration 
profiles of the two chemosensors in the presence of increasing amounts of Mg2+ in 
MEOH:MOPS. The titration profile of DCHQ1 was also evaluated in DPBS (Fig. 5.1). 
Due to the different luminescence quantum yields of the Mg complexes formed with 
the two dyes, the comparison was performed using concentrations of 25 µM for 
DCHQ1 and 10 µM for DCHQ5.  
 
  
Figure 5.1: Fluorescence titration of DCHQ1 (green line, grey dots) and DCHQ5 
(black line, grey dots) with Mg2+ respectively at 500 and 510 nm in MeOH:MOPS. 
The fluorescence intensities are reported normalized for the concentration of the 
respective probe (25 µM for DCHQ1 and 10 µM for DCHQ5). Titration of DCHQ1 in 
DPBS (green line, grey squares) is also reported for comparison. 
 
 
Fig. 5.1 shows that DCHQ5 has a higher response (represented by the steeper slope) 
and a higher fluorescence intensity than DCHQ1 for all the Mg concentrations tested. 
It is also to be noted that the fluorescence intensities were normalized by the 
respective concentration of the two probes (25 µM for DCHQ1 and 10 µM for 
DCHQ5) as indication that the better performance of DCHQ5 was obtained even 
when using much lower amount than DCHQ1. 
 
All chemosensors are subject to photobleaching to a variable extent, depending on 
their intrinsic photostability and on the illumination parameters [130]. Since 
photobleaching causes a decrease in signal strength in proportion to the time and 
intensitity of excitation [131], we assessed the fluorescence stability over time in 
presence of saturating (Mg:dye ratio of 100:1) and not saturating (Mg:dye ratio of 
1:2) concentration of magnesium. 
 In Table 5.1 are reported the percentage of fluorescence attenuation after 30 
minutes of continuous exposure to the excitation light for the two dyes in 
MeOH:MOPS and also in DPBS for DCHQ1. 
 
Table 5.1. Percentage decrements of fluorescence intensity of the two probes at 500 
nm for DCHQ1 and at 510 nm for DCHQ5, after 30 minutes of continuous exposure 
to the excitation light (exc= 360 nm). 
 
Mg:dye 1:2 100:1 
DCHQ1 in MeOH:MOPS 19% 4% 
DCHQ1 in DPBS 44% 2% 
DCHQ5 in MeOH:MOPS 15% 8% 
 
 
Results shown that the response of the two dyes in MeOH:MOPS is similar, with a 
maximum signal decrease in presence of not saturating Mg concentration.  
We have also performed the stability test of DCHQ1 in DPBS, because for that probe 
it is reported a protocol for the assessment of the intracellular Mg content in DPBS 
[120]. Under these conditions, we observed a marked decrease of fluorescence 
intensity at the Mg:dye ratio of 1:2, used in the previously proposed intracellular Mg 
assay protocol. 
 
5.1.2 Design of a new protocol for the quantitative assessment of total 
intracellular magnesium 
Despite the remarkable performances of DCHQ5 in MeOH-based buffer, the 
perspective to perform assays in cells it is necessarily linked to the use of 
physiological buffer.  
Therefore, we decided to design a new protocol to quantitatively assess intracellular 
total magnesium in sonicated cellular samples by using a simple spectrofluorimetric 
assay, based on a standard titration curve. 
 In particular, DCHQ1 was dissolved in DPBS while DCHQ5 in MeOH:MOPS added 
with 10% of DPBS, which is the buffer of the sonicated cellular samples. 
The addition of that amount of the physiological buffer did not interfere with the 
fluorescence response of DCHQ5. Indeed, also in the presence of DPBS, the 
fluorescence intensity of the phenyl derivative remain higher than DCHQ1, and for 
these assays the concentration used for DCHQ5 was 15 µM, against 25 µM used for 
DCHQ1.  
The fluorescence intensities of known amounts of MgSO4 registered for the standard 
curves were used to determine the Mg concentration of the unknown sonicated 
cellular samples suspended in DPBS by the interpolation of their fluorescence with 
the relative standard curve. 
We compared the data obtained using DCHQ5 and DCHQ1 in a total of 24 cell 
samples with various magnesium content, with the ones given by AAS, which is 
currently the reference technique for the quantification of total intracellular 
magnesium (Fig. 5.2).  
 
Figure 5.2. Correlation between the total intracellular magnesium assessed by AAS 
and DCHQ1 (on the left) or DCHQ5 (on the right). The identity line is plotted for 
comparison. 
 
 
 Results show that the values of Mg concentration assessed by both probes overlap 
the AAS measurements.  
Statistical analysis showed that the data could be well fitted with linear equations 
and we also found a good correlation between the data sets given by the two 
techniques for both probes, with an R-squared of 0.93 for DCH1 and 0.98 for DCHQ5. 
We also performed a paired t-test between the dye fluorimetric assays and AAS. 
Results shown no significance for DCHQ1, while DCHQ5 showed a p < 0.01. The 
regression line equation of DCHQ5 has coefficients closer to the identity line than 
those of DCHQ1. However, the paired t-test analysis showed that DCHQ5 displays a 
positive systematic deviation from AAS measurements, as can be also noted by the 
comparison of the correlation with the identity line. 
It is worth noting that DCHQ5 can quantitatively assess intracellular total 
magnesium in much slower number of cells (of the order of 30-50x103 cells/mL) 
compared to DCHQ1, where the minimum cells size per mL is 100x103.  
 
To establish the analytical sensitivity of our spectrofluorimetric assay, we then 
evaluated the Limit of Detection (LOD) for both probes in the assay buffer 
(MeOH:MOPS +10% of DPBS for DCHQ5 and DPBS for DCHQ1) and also after the 
addition of the sonicated cellular samples (Table 5.2). 
As it is reported in the Table 5.2, for cell populations of 250x103 and 100x103 the 
LOD of the two probes is the same.  
As mentioned above, the minimum amount of cells detected by DCHQ1 is 100x103 
cells per mL, while DCHQ5 can quantify Mg even in smaller samples; therefore for 
DCHQ5 it was possible to establish also the LOD for cellular samples of 50x103.  
 
 
 
 
 
 
 
 
 Table 5.2. Limit of detection (LOD) of DCHQ1 and DCHQ5 reported in M evaluated 
in the buffer solution (DPBS for DCHQ1 and MeOH:MOPS +10% of DPBS for DCHQ5) 
and after the addition of cells sample. 
 
Mg2+ LOD in M 
in buffer solution 
Mg2+ LOD in M 
sample size (cells/mL) 
    50 × 103 100 × 103 250 × 103 
 DCHQ1 0.3  n.d 0.2 0.5 
 DCHQ5 0.2  0.2 0.2 0.5 
 
 
In parallel, we have also assessed the detection limit in AAS (0.2 µM) (see paragraph 
4.8) and interestingly the LOD of the AAS, a technique generally considered as the 
gold standard, is of the same order of the LOD measured for DCHQ5 at the lowest 
sample size, as a proof of the great analytical value of our simple spectrofluorimetric 
procedure. 
 
5.1.3 Cytofluorimetric assays in viable cells  
Sonication of samples is a necessary step to quantitatively assess the total cell 
magnesium by fluorescence spectroscopy, because intracellular membranes and/or 
lipophilic environments enhanced the fluorescence of the probes [120]. Indeed, it is 
possible to discriminated substantial changes in total cell magnesium contents by 
semi-quantitative analysis in viable cells loaded with our dyes in DPBS [114].  
In this context, one of the most important limitation of DCHQ1 is its poorly 
intracellular retention. On the contrary, DCHQ5 is highly retained inside the cells. 
Therefore, we performed cytofluorimetric assay to compare the intracellular 
retention of the two probes after washing, as well as their fluorescence stability over 
time inside the cells. 
In Fig. 5.3 are reported the mean channel of DCHQs fluorescence of the viable cells 
in the aforementioned conditions. 
  
Figure 5.3: Mean channel of fluorescence distribution of cells stained with DCHQ1 
(on the left) and DCHQ5 (on the right). The measurements were also exploited after 
the first and the second washing to evaluate the intracellular retention. Data were 
acquired over a time lapse of 60 minutes after staining. Experiments repeated three 
times. Data are expressed as mean±SD. 
 
 
As regard the fluorescence stability over time, data shown that the staining is stable 
up to 60 minutes for both probe, with just a maximum decrease of 20% for DCHQ5. 
The fluorescence decay can be ascribed to the suffering of cells induced by the 
capability of DCHQ5 to compete with ATP in binding Mg2+. Indeed, the micromolar 
Kd(Mg2+) of the dye is of the same order of magnitude as ATP. 
Differences between DCHQ1 and DCHQ5 were more relevant when we considered 
the intracellular retention evaluated by the mean channel of fluorescence 
distribution after washing. Data showed that DCHQ5 was much more efficiently 
retained inside the cells than DCHQ1. 
Indeed, the overall fluorescence decrease of DCHQ5 is around the 30% of the initial 
value, with an almost negligible drop after the second washing. Conversely, DCHQ1 
fluorescence progressively decrease after the second washing, with a total 
decrement of 80% from the initial value. These results suggest that for DCHQ5 the 
first washing eliminates only the dyes loosely bound to the cellular surface, and not 
the probe entrapped within the cell, which unlike DCHQ1, is not removed by the 
second washing.  
 Another important aspect that has to be considered is the concentration of the dyes 
used allowing the best compromise between high signal and low cytotoxicity. For 
the cytofluorimetric assays the amount of DCHQ5 required is one fifth (5 µM) than 
that for DCHQ1 (25 µM), a further evidence of the great analytical value of DCHQ5 
also in live cells analysis.  
5.2 Fluorescence Lifetime Imaging of DCHQ5 
A common characteristic of the members of the DCHQ family is to show a bi-
exponential fluorescence lifetime decay in the intracellular environment. In 
particular, for the mother probe DCHQ1 are reported two fluorescence lifetime by 
using Time-Correlated Single Photon Counting (TCSPC) in cell suspensions of HC11 
and HL60 cells [115]. However, for DCHQ1 the excitation is possible only in the UV 
region, where the background interference due to cell auto-fluorescence, notably 
limit its application in fluorescence lifetime imaging (FLIM) microscopy.  
FLIM has been recognized as a powerful microscopy technique that can map the 
spatial distribution of the fluorescence lifetime of a fluorophore in a single cell 
providing quantitative information on intracellular environments. Furthermore, 
this technique is independent of fluorophore concentration, fluorescence intensity, 
light path length and photobleaching [132].  
Among the members of the DCHQ family, DCHQ5 possesses the unique feature to be 
excitable in the visible region. This property renders this dye very interesting for 
fluorescence lifetime imaging (FLIM) applications, since in the visible region the 
background interference is minimized.  
Therefore, we also performed FLIM measurements in collaboration with the group 
of Professor Paola Taroni at the Politecnico of Milan to explore the capability of 
DCHQ5 to obtain FLIM image of intracellular Mg. 
 
In Fig 5.4 are reported the data obtained in a typical experiment in LoVo cells, were 
are depicted the intracellular distribution maps of Ƭ1 and Ƭ2 and of the amplitude 
A1 and A2, which represent the complex Mg:dye (see equation in paragraph 4.12).  
  
Figure 5.4: Intracellular distribution maps of the two lifetimes decay Ƭ1 and Ƭ2 and 
of the corresponding A1 and A2 in a typical LoVo cell loaded with DCHQ5 5µM in 
DPBS. 
 
 
Results displayed a homogeneous distribution of Ƭ 1 and Ƭ 2 inside the cell, while 
we observed different pattern of distribution of A1 and A2, which is an extremely 
interesting data, since the amplitudes represent the patterns of distribution of the 
complex Mg:dye inside the cells. 
Indeed, FLIM image of intracellular Mg has never been done so far, and in light of 
these achievements, now we can further understand and explain previously 
reported results of our group about the intracellular distribution of magnesium by 
two-photon confocal imaging [114].   
As it is shown in the Fig.5.5, taken from Marraccini et al, cells loaded with DCHQ5 
disclosed a diffused fluorescence over the cytosol with a higher intensity in the 
perinuclear region. Moreover, DCHQ5 presented a high fluorescence signal also in 
the plasma cell membrane, accordingly with the fluorescence enhancement of 
DCHQs derivatives in the lipophilic environment [120].  
Matching together the results of the two imaging technique, we can deduce that the 
higher fluorescence of DCHQ5 previously observed by our group in the cell 
membranes by two-photon microscopy was related to a higher concentration of 
 magnesium in these environments and not to the effect of a heterogeneous 
distribution of the two lifetimes within the cell, as we have proved.  
 
 
Figure 5.5: Two photon fluorescence microscopy image (exc=750 nm), of ROS rat 
osteosarcoma cells stained with DCHQ5 10µM. (Panel D taken from the Fig. 6 of 
Marraccini et al. 2012 [114]). 
 
 
In particular, the higher fluorescence intensity found in the perinuclear region, 
corroborates the evidence that in this area there is a physiological accumulation of 
magnesium due to the presence of several sub-cellular organelles [109], [133]. 
Also in the plasma membrane, DCHQ5 showed a high fluorescence signal intensity 
which, according to our results, would correspond to a high concentration of Mg2+. 
This interpretation is supported by the “Membrane Magnesium Mitosis” model of 
cell proliferation control postulated by Rubin [81]. According to this theory, the pool 
of magnesium bound to the inner surface of the plasma membrane plays a crucial 
role in the regulation of cell proliferation. Indeed, membrane perturbations, induced 
by the binding of growth factors to their receptors, provoke the release of 
membrane bound magnesium, which triggers the proliferating signaling to the 
nucleus.  
 
 
 
 
 
 5.3 Study of the magnesium involvement in the commitment of 
human adipose-derived mesenchymal stem cells 
The real contribution of magnesium to the complex and articulate process of cell 
differentiation is not clear and data reported in literature are few and discordant. 
Among the field of cell differentiation, in the last decades, growing interest have 
been arising to the application of human mesenchymal stem cells (hMSCs) for 
regenerative medicine [56]. Indeed hMSCs are able to self-renew and possess 
multipotent differentiation properties. In particular, adipose tissue has been 
identified as an abundant and easily accessible source of multipotent adipose-
derived stem cells (hASCs) [134]. Furthermore, it has been reported that the 
treatment of hMSCs with a mixture of differentiating agents, such as hyaluronic, 
butyric and retinoic acids, remarkably increased the multipotent commitment of 
these cells [56]–[58].  
 
5.3.1 Total magnesium content and cell cycle analyses of hASCs in complete 
and Mg-free medium 
Based on the findings mentioned above, we decided to investigate the role of 
magnesium in the preconditioning of human adipose-derived mesenchymal stem 
cells (hASCs) with a mixture of hyaluronic, butyric and retinoic (HBR) acids.  
In Fig. 5.6, panel A, are reported the total Mg concentrations of treated (HBR) and 
untreated (Ctr) hASCs cells in complete medium at 0, 2, 5 and 10 days of analysis. 
The treatment with the cocktail of differentiating agents was carried out at time 0.  
The measurements were performed in sonicated sample by using the fluorescent 
probe DCHQ5 as reported in paragraph 4.7. 
In parallel we have also evaluated the cell cycle distribution by flow cytometry 
(Panel B).   
 
 Figure 5.6: Panel A: Total Mg concentration of treated (HBR, red bar) and untreated 
(Ctr, black bar) hASCs cells at 0, 2, 5 and 10 days of analysis in complete medium. 
Measurement were carried out in sonicated sample by using the fluorescent probe 
DCHQ5 
 *** Significantly different from the control, p<0.001. Panel B: Cell cycle distribution 
in hASCs treated and untreated at the same times.  
 
 
 
Interestingly, the total magnesium quantification by DCHQ5 revealed a surprising 
and progressive increment of magnesium in treated cells from day 2 to 10 compared 
to control cells. In particular, at time 5 and 10 days the increase in cells treated with 
HBR is statistically significant. As shown in Fig. 5.6, panel A, total intracellular 
magnesium content at 5 days in cells preconditioned with HBR is 84.6±10.5 
nmol/106 cells, two times more than in control cells, which present an average 
concentration of 37.6±6.1 nmol/106 cells. At 10 days, the difference is even more 
relevant, with an increment in treated cells (142.8±5.4 nmol/106 cells) more than 
three times higher than the control (57.8±22 nmol/106 cells). Moreover, the 
increment of magnesium in treated cells is accompanied by a remarkable 
accumulation in the G2/M phase of the cell cycle as compared to the untreated 
samples at all time of analysis (2, 5 and 10 days), as shown in Panel B.  
It is important to highlight that quantification of total intracellular Mg by using 
DCHQ5 allowed us to accurately assess total magnesium content in very small 
cellular samples, of the order of 25-30 x 103 cells/mL. Taking into account the 
 relatively small number of cells that we had for these analyses, these measurements 
could not be carried out by other available techniques, as AAS, that requires a more 
consistent amount of cells, at least 1x106/mL.  
Since extracellular Mg2+ availability differently affected cell differentiation 
depending on the cell model investigated, we have also performed the same 
experiments in Mg-free medium. 
In figure 5.7, panel A, are reported the total Mg concentrations of treated (HBR -Mg) 
and untreated (Ctr -Mg) hASCs cells in Mg-free medium at 0, 2, 5 and 10 days of 
analysis. 
Also in these set of experiments, the treatment with the cocktail of differentiating 
agents was carried out at time 0. Again, in parallel we have evaluated the cell cycle 
distribution by flow cytometry (Panel B).     
 
Figure 5.7: Panel A: Total Mg concentration of treated (HBR -Mg) and untreated 
(Ctr -Mg) hASCs cells at 0, 2, 5 and 10 days of analysis in Mg-free medium. 
Measurement were carried out in sonicated sample by using the fluorescent probe 
DCHQ5. Panel B: Cell cycle distribution in hASCs treated and untreated at the same 
times.  
 
 
As regard the total magnesium content measured by DCHQ5, in Mg-free medium we 
do not observed significant difference between control and treated cells at any 
 times, as expected since the cells were kept in a complete Mg-free medium for all the 
time. 
The magnesium fluctuations of both control and treated cells, are to be ascribed to 
the internal heterogeneity of hASCs and are amplified by the large scaling adopted 
in the graphic.  
Even in this set of experiment, we observed an accumulation in the G2/M phase of 
the cell cycle as compared to the untreated samples at all time of analysis (2, 5 and 
10 days), as shown in Panel B, even if the accumulation in G2/M phase at 2 days is 
more marked in complete medium that in Mg-free (HBR: G2/M 52.09 %; HBR –Mg: 
G2/M 31.49%). 
Furthermore, in treated and Mg-deprived cells the G1 phase is higher than treated 
cells in complete medium at all times. 
 
Taken together, these findings prompt to hypothesize that the pre-commitment of 
hASCs is strictly related to the block of the cell cycle at G2/M phase, since in both 
complete and Mg-free medium, the accumulation in G2/M took place only when the 
cells are exposed to the mixture of differentiating agents. However, in treated and 
Mg-deprived cells the accumulation in G2/M increases over time, while in complete 
medium it is already at the maximum after two days of treatment. This evidence 
suggests that magnesium deprivation could delay this accumulation. 
This is an unusual results if compared to data reported in literature, since recent 
studies shown that Pluripotent Stem Cells (PSC) are more prone to respond to 
differentiation in the G1 phase of the cell cycle, suggesting a correlation between 
PSC differentiation and G1 phase [135]. Anyway, understanding the mechanisms 
that govern the processes of self-renewal and lineage specification continues to be 
a few explored field. Moreover, in literature there are no evidence about the cell-
cycle state and pre-commitment of hASCs.  
On the other hand, in agreement of our observation, it is reported the induction of 
cell differentiation in G2/M phase in rat neural cells exposed to apigenin [136] and 
in Caco-2 cells treated with nocodazole [137]. 
Moreover, it is also reported that butyric acid is the major effector of cell cycle 
accumulation in G2/M in a dose dependent manner [138]. 
 As regard the magnesium content of hASCs, taking into account the time dependent 
increase of total intracellular magnesium of treated cells in complete medium, a 
correlation between magnesium and cell commitment seems to exist. Indeed, these 
increase is a counterintuitive results since the knowledge that proliferating cells 
contain more Mg2+ than resting ones is well established, coherently with the 
promoting role of Mg2+ on protein and DNA synthesis [101]. Conversely, hASCs are 
poor proliferating cells with a slow rate of growth, which is further reduced by the 
treatment with the cocktail of differentiating agent. In fact, the cocktail of 
differentiating agents stimulated the pre-commitment of hASCs, which is a process 
that necessarily implicates a metabolic stimulus and reorganization aimed at 
achieving a terminal commitment. For example, it is reported that HBR increase the 
expression of a number of gene enrolled in stem cell survival and/or cardiovascular 
commitment in vitro [139]. Hence, HBR preconditioning of hASCs is far from being 
a quiescent state.  
 
5.3.2 Analyses of gene expression of a panel of multilineage markers in 
complete and Mg-free medium 
 
In order to understand whether and how magnesium availability was involved in 
HBR preconditioning of hASCs, we examined the gene expression of a panel of 
markers representing the multilineage potential of these cells, such as GATA-4, NKX-
2.5, HGF, KDR, NEUROG and NANOG. 
GATA-4 (GATA Binding Protein 4) and NKX-2.5 (NKX2 Homeobox 5) are two key 
regulators of cardiogenic commitment, in particular, the latter is the earlier known 
marker of the cardiac lineage [140], [141], HGF (Hepatocyte Growth Factor) and 
KDR (Kinase Insert Domain Receptor) are involved in the orchestration of 
vasculogenesis and proper capillary formation [142], [143], NEUROG (Neurogenin) 
is a marker of neurogenic commitment [144] while NANOG ( Nanog Homeobox) is a 
gene involved in the maintenance of stem cells pluripotency [145].  
We evaluated the gene expression at 5 and 10 days for treated and untreated cells 
both in complete and Mg-free medium.   
 In Figure 5.8, are depicted the mRNA level of the cardiac lineage-promoting genes 
GATA-4 (on the left) and NKX-2.5 (on the right). 
 
Figure 5.8: Analysis at 5 and 10 days of gene expression of the cardiac lineage-
promoting genes GATA-4 (on the left) and NKX-2.5 (on the right) in complete 
medium (control (Ctr) and treated (HBR) cells), and in Mg-free medium (control (Ctr 
-Mg) and treated (HBR -Mg) cells). 
*Significantly different from the treated samples in complete medium (HBR), 
p<0.05. 
 
 
Results shown that the gene expression of the two key regulators of cardiogenic 
commitment is strongly enhanced in cells treated with HBR and grown under Mg-
free conditions compared to treated cells in complete medium. In particular the gene 
expression acceleration is significantly different for GATA-4 only at 5 days, while for 
NKX-2.5 at both 5 and 10 days.  
As regard the gene expression of the vasculogenesis markers HGF and KDR, as 
shown in Fig. 5.9, we observed the same trend. 
 
 
  
Figure 5.9: Analysis at 5 and 10 days of gene expression of vasculogenic genes HGF 
(on the left) and KDR (on the right) in complete medium (control (Ctr) and treated 
(HBR) cells), and in Mg-free medium (control (Ctr -Mg) and treated (HBR -Mg) cells. 
**Significantly different from the treated samples in complete medium (HBR), 
p<0.01. 
 
 
 
Indeed, also for this panel of markers, in Mg-free medium the mRNA level of treated 
cells is further enhanced, with significant differences both at 5 and 10 days for HBR, 
compared to treated cells in complete medium.   
Lastly, as shown in Fig. 5.10, in order to have a complete picture of the possible cells 
lineages of hASCs, we evaluated the effects of Mg deprivation also in NEUROG, our 
markers for the neurogenic commitment and NANOG, a gene involved in the 
maintenance of the pluripotency, to investigate in parallel even the self-renewal 
potentiality in our sistem. 
 
 
  
Figure 5.10: Analysis at 5 and 10 days of gene expression of neurogenic gene 
NEUROG (on the left) and of NANOG (on the right), which is a gene involved in the 
maintenance of the pluripotency, in complete medium (control (Ctr) and treated 
(HBR) cells), and in Mg-free medium (control (Ctr -Mg) and treated (HBR -Mg) cells. 
**Significantly different from the treated samples in complete medium (HBR), 
p<0.01. 
 
 
Also for these markers, we observed the same trend even if the differences are 
statistically significant only for NEUROG at 5 days.  
 
Taking together the data about the gene expression, they seems to indicate that the 
effects of the treatment with HBR is strongly accelerated by the magnesium 
deprivation. 
Indeed, in hASCs stimulated by HBR, for all the gene under investigation, we have 
found an increase of the gene expression in Mg-free medium compared to complete 
one. Even though this trend was present in each experiments, we had high standard 
deviation for NEUROG and NANOG at 10 days, for KDR both at 5 and 10 days and for 
GATA-4 at 10 days, and the mean gene expression reported for these markers did 
not reached the threshold of significance.    
   
 
Since the gene expression of the panel of markers that we have investigated is 
enhanced by the Mg deprivation, to further dissect the involvement of magnesium 
 in the multilineage modulation of gene expression, we decided to examine the 
response of these markers after the re-addition of magnesium to the deprived 
medium. 
In particular, we grown the pre-conditioned cells in Mg-free medium for 5 days and 
then we add again MgCl2 1mM to the medium, for other 5 days. Hence, the gene 
expression was evaluated at the final time of 10 days and we compared treated cells 
in all condition under analysis: complete medium (HBR, red bar), Mg-free medium 
(HBR –Mg, blue bar) and Mg-free medium with the re-addition of MgCl2 at day 5 
(HBR Mg re-add, green bar). 
In Fig. 5.11 are depicted the results at 10 days of all the markers in the three 
conditions mentioned above.   
 
Figure 5.11: Analysis at 10 days of gene expression of GATA-4, NKX-2.5, HGF,  
NEUROG and NANOG (on the left) and of KDR (on the right) of treated cells in 
complete medium (HBR, red bar), Mg-free medium (HBR -Mg, blue bar) and after 5 
days of Mg re-addition to the deprived medium (Mg re-add, green bar). All the values 
were normalized respect to their controls. 
** p<0.01, *** p<0.001: significantly different from the treated samples deprived of 
magnesium and then supplemented with MgCl2 for 5 days (HBR Mg re-add). 
 
 
 
Results shown that the re-addition of magnesium for 5 days to the deprived medium, 
further modulated gene expression, but in a negative way: in fact the expression of 
 all the genes decreases to the same level of that obtained in samples grown in 
complete medium. 
 
Altogether, the results clearly show that the magnesium deprivation trigger the 
enrichments of the multilineage preconditioning of hASCs exposed to the mixture of 
differentiating agents, since gene expression of the markers investigated was 
strongly enhanced only in the cells constantly grown in Mg-free medium. 
 
 
 
  
 PART II 
 
 
Recently, one of the main focus of life science in elemental quantification is direct to 
single cell analysis. Indeed, the possibility to have a map of whole single cells could 
give important informations about morphology of the cell, amount of element 
constituting the cell and more important the elemental distribution and 
compartmentalization in the cell organelles.  
In particular, synchrotron x-ray fluorescence microscopy is a highly sensitive 
method for mapping elements distribution in single cells at nanoscale resolutions 
[128]. 
The knowledge that this kind of techniques can gives about cell biology are 
extremely significant but the information obtained in small group of single cells 
should not disregards the behaviour of a large population of cells.  
 
In this context, in the second part of this study we decided to compare single cells 
analysis performed with synchrotron-based fluorescence and cell population 
analysis carried out by the fluorescent chemosensor DCHQ5. In particular, we 
compared the concentration of intracellular Mg obtained with the two methods.  
Single cells analyses were performed by adopting a multidisciplinary approach, with 
the use of complementary techniques and implementation of custom-made 
algorithms which allowed us to obtain molar concentration maps of Mg2+ and of 
fundamental life elements, such as carbon (C), nitrogen (N) and oxygen (O) in whole 
single cell. To do this, we combined Atomic Force Microscopy (AFM), with 
synchrotron based X-ray fluorescence Microscopy (XRFM) and Scanning 
Transmission X-ray Microscopy (STXM) in whole dehydrated cells [99].  
All the synchrotron-based fluorescence analyses were carried out at Twinmic beam 
line at the Elettra synchrotron of Trieste. 
 
 
 5.4 Synchrotron-based single cells analysis 
We have analysed three different cellular models variously treated to obtain 
differences in the total magnesium content. Endothelial cells isolated from the 
umbilical vein (HUVEC) were measured in a single experiment where we have 
analysed five wild type HUVEC (controls) and five HUVEC genetically engineered to 
silence TRPM7 (TRPM7 silenced) after the expositions of cells to Doxycicline 
(2ug/ml) for 48 h (Tab1). In the second experiments, we investigated the different 
distribution and content of intracellular Mg in SaOS2 cells cultured in a medium 
containing 0.5% FBS in the absence of MgCl2 to synchronize cells in G0/G1 phase 
and reduce intracellular Mg content. After 24h of starvations, control cells (+Mg) 
were kept for other 24 h in a Mg-free medium supplemented with MgCl2 1 mM, while 
the deprived cells (–Mg) were kept for the following 24 h in the Mg- free medium. In 
total we have analysed four controls and four deprived samples. 
Regarding the last cellular model, LoVo cells were acquired in three different 
experiments where we were interested to study the intracellular concentration and 
distribution of magnesium in LoVo sensitive (LoVo S) and resistant (LoVo R) to 
doxorubicin, one of the most used anticancer drug.   
This approach allow to obtain physical property such as density, volume and mass 
in addition to elemental composition such ad concentration. 
Table 5.3 (HUVEC and SaOS2), and Table 5.4 (LoVo) shown the molar concentrations 
of carbon (C), nitrogen (N), oxygen (O), and magnesium (Mg) derived by 
synchrotron-based single cells analysis in the three cellular. 
 
 
 
 
 
 
 
 
 
 Table 5.3: Whole cell parametersa in HUVEC cells, wild type (Controls) and silenced 
for TRPM7 (TRPM7 silenced) and in in SaOS2 cells, cultured in presence (+Mg) and 
absence (-Mg) of Mg.  
 
 
a For each cell, total volume calculated from AFM and total mass and mean density 
calculated from the respective mass and density maps are reported. The calculated 
concentration of the elements are also reported for each cell (HUVEC: 4 controls and 4 
TRPM7 silenced; SaOS2: 4 +Mg and 4 -Mg). SD, standard deviation; CV, coefficient of 
variation. For Mg concentration the value of the t-test is also reported. 
 
 
 
Sample Fixation Density Volume Mass
g/cm
3
µm
3 pg C (mM) N (mM) O (mM) Mg (mM)
H6 Cryo 1.79 114 204 69941 23296 19311 109
H7 Cryo 1.14 125 142 44552 14015 13298 89
H8 Cryo 1.31 273 358 51512 14057 12089 90
H9 Cryo 1.62 161 261 61020 19788 16451 111
H10 Cryo 1.58 107 169 62571 19621 16946 102
1.49 156 227 57919 18155 15619 100
0.26 69 86 9944 4037 2913 10
17% 44% 38% 17% 22% 19% 10%
H1 Cryo 1.37 156 214 43202 13242 11156 87
H2 Cryo 1.44 147 211 57878 20996 17706 164
H3 Cryo 1.36 209 283 51805 19682 15763 111
H4 Cryo 1.45 129 187 53719 21419 16429 104
H5 Cryo 1.4 142 199 56929 24314 17842 58
1.40 156.60 218.80 52707 19931 15779 105
0.04 30.88 37.45 5847 4104 2728 39
3% 20% 17% 11% 21% 17% 37%
n.s
Sample Fixation Density Volume Mass
g/cm
3
µm
3 pg C (mM) N (mM) O (mM) Mg (mM)
S1 Cryo 1.21 110 134 49765 26786 16761 92
S2 Cryo 1.27 110 140 43537 23730 14017 87
S3 Cryo 1.32 81 107 50450 23628 16008 102
S4 Cryo 1.33 111 148 51088 23210 12991 87
1.28 103 132 48710 24339 14944 92
0.06 15 18 3491 1647 1742 7
4% 14% 13% 7% 7% 12% 8%
S5 Cryo 1.30 115 149 51178 26192 15068 45
S6 Cryo 1.51 211 318 61004 25265 13497 31
S7 Cryo 1.46 127 185 61353 24955 12974 26
S8 Cryo 1.40 203 283 57765 22292 14161 31
1.42 164 234 57825 24676 13925 33
0.09 50 80 4717 1674 904 8
6% 30% 34% 8% 7% 6% 25%
p<0.05
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 Table 5.4: Whole cell parametersa in LoVo cells, sensitive and resistant to 
doxorubicin 
 
 
a For each cell, total volume calculated from AFM and total mass and mean density 
calculated from the respective mass and density maps are reported. The calculated 
concentration of the elements are also reported for each cell (14 LoVo S and 11 LoVo R). 
Results of three experiments, indicated as A, B, C. 
SD, standard deviation; CV, coefficient of variation. For Mg concentration the value of the t-
test is also reported. 
 
 
Sample Fixation Density Volume Mass
g/cm
3
µm
3
pg C (mM) N (mM) O (mM) Mg (mM)
L1 A Chem 1.16 174 201 38388 17286 15059 55
L2 A Chem 1.09 176 191 44419 17657 14699 42
L3 A Chem 1.16 106 123 45222 20465 16568 17
L4 B Cryo 1.43 90 129 58026 17511 15823 43
L5 B Cryo 1.11 261 289 40718 13725 12964 84
L6 B Cryo 1.14 347 397 43020 12602 12203 95
L7 B Chem 1.75 144 253 56173 24654 20926 59
L8 B Chem 1.81 155 280 48704 25460 25051 72
L9 C Cryo 1.11 177 196 42461 18264 15586 73
L10 C Cryo 1.13 164 186 43930 17407 14136 24
L11 C Cryo 0.95 81 77 36900 13515 12246 51
L12 C Cryo 1.22 133 162 46114 19111 14774 95
L13 C Cryo 1.09 112 122 46235 17106 14144 45
L14 C Cryo 1.24 196 243 51653 18014 15191 102
1.24 165 204 45855 18056 15669 61
0.25 70 84 6105 3688 3448 27
20% 42% 41% 13% 20% 22% 43%
L17 B Cryo 0.97 139 135 36764 14150 13168 83
L18 B Cryo 1.18 171 202 40057 16216 14432 87
L19 B Chem 1.83 142 261 59311 27845 23832 66
L20 B Chem 1.42 192 272 47011 21828 18849 60
L21 C Cryo 1.11 78 87 43338 23071 17314 79
L22 C Cryo 1.21 73 88 48208 27085 18380 65
L23 C Cryo 1.52 157 239 56129 31196 22804 96
L24 C Cryo 1.24 65 81 44821 28428 18980 62
L25 C Cryo 1.29 89 115 49693 25146 17551 76
L26 C Cryo 0.95 44 42 39746 17581 13302 52
L27 C Cryo 1.20 83 100 44771 21487 15559 47
1.27 112 147 46350 23094 17652 70
0.25 49 81 6839 5465 3498 15
20% 44% 55% 15% 24% 20% 22%
n.s
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 As is shown in the tables below, this approach allow to obtain physical property such 
as density, volume and mass in addition to elemental composition, in particular the 
concentration. 
Focusing the attention on the results about Mg content, using single cells analysis, 
we found a statistically different quantities of Mg in SaOS2 cells (p<0.001), denoting 
a decreasing of Mg in deprived cells (33±8 mM), compared to control cells (92±7 
mM).  
 
The main goal of our multidisciplinary approach was the possibility to reconstruct 
detailed maps of the spatial distribution of cell density and mass by merging STXM 
information (electron density of the sample) and cell thickness map obtained by 
AFM aligned onto STXM space, providing the volume of each single cell analysed. 
Finally, molar concentration distribution were obtained by normalizing the maps of 
fluorescence intensity respectively to the volume maps. 
This accurate approach provides both submicrometer spatial resolution and 
quantification of elements down to 106 atoms/µm3 (based on the minimum 
concentration detected in a single pixel for each element, i.e., 1 mM) as shown in Fig. 
5.12, for a representative cell. 
 
 
 
  
 
Figure 5.12: (Top row, from the left): morphology, X-ray transmission, and X-ray 
fluorescence images of a LoVo S (cell L5 B reported in TableXXX), acquired by atomic 
force microscopy (AFM), scanning transmission X-ray microscopy (STXM), and X-
ray fluorescence microscopy (XRFM), respectively. The XRFM image reports the 
sum of all the channels of the spectrum. In the top right panel is shown a 3D 
rendering of AFM. (Second row): from AFM and STXM is then calculated a map of 
the spatial distribution of the cell density and mass. (Third row): Elemental maps of 
molar concentration of C, N, O and Mg.  
 
 
5.5 Cell population analyses by DCHQ5 
In parallel to the synchrotron-based fluorescence analyses we quantified the total 
amount of intracellular Mg in a large population of the same samples by using 
DCHQ5 (Table 5.5 and Table 5.6). 
Moreover, we calculated the exact volume of all the cells type under investigation by 
using Beckman coulter counter (see Paragraph 4.15), and we normalized the 
amount of magnesium assessed by spectrofluorimetric assay to the calculated cells 
volumes, in order to obtain the molar concentration of total intracellular Mg in a 
large population, as reported in Table 5.5 for HUVEC and SaOS2 cells, and in Table 
5.6 in LoVo cells. 
 
 
  
Table 5.5. Molar concentration of Mg assessed by DCHQ5 in in HUVEC (controls and 
TRPM7 silenced) and SaOS2 (+Mg and –Mg) cells a. The mean values of diameter and 
volume are also reported. The Mg concentrations assessed by DCHQ5, expressed in 
nmol/106 cells were normalized to the respective mean volume to obtain the molar 
concentrations. The p value is also reported. 
 
a For each cell lines, the mean values of diameter and volume are also reported. The Mg 
concentrations assessed by DCHQ5, expressed in nmol/106 cells were normalized to the 
respective mean volume to obtain the molar concentrations.  
SD, standard deviation; CV, coefficient of variation, the value of the t-test is also reported. 
 
 
Cellular Model diameter volume volume
HUVEC  (μm)  (μm
3
)  (L) (nmol/10
6
cells) (mmol) (mM)
49.7 4.97E-11 21.9
59.5 5.95E-11 24.4
48.5 4.85E-11 21.4
51.5 5.15E-11 22.3
Mean 52.3 22.5
SD 4.3 1.1
CV 8% 5%
51.8 5.18E-11 21.2
56.0 5.60E-11 25.2
49.7 4.97E-11 22.8
Mean 52.5 23.1
SD 2.6 1.6
CV 5% 7%
p value: 0.71
Cellular Model diameter volume volume
SaOS2  (μm)  (μm3)  (L) (nmol/106cells) (mmol) (mM)
30.1 3.01E-11 13.35
34.0 3.40E-11 15.07
29.2 2.92E-11 12.95
Mean 31.1 13.8
SD 2.1 0.9
CV 7% 7%
15.6 1.56E-11 7.6
18.5 1.85E-11 9.1
15.7 1.57E-11 7.7
Mean 16.6 8.1
SD 1.3 0.7
CV 8% 8%
p value: 0.019
DCHQ5 (cells population analysis)
[Mg]
Controls 16.4 2266 2.27E-12
TRPM7 silenced 16.3 2437 2.44E-12
[Mg]
+ Mg 16.6 2394 2.39E-12
- Mg 16.5 1987 1.99E-12
 Table 5.6. Molar concentration of Mg assessed by DCHQ5 in LoVo (sensitive and 
resistant) cells a. The mean values of diameter and volume are also reported. The Mg 
concentrations assessed by DCHQ5, expressed in nmol/106 cells were normalized 
to the respective mean volume to obtain the molar concentrations. The p value is 
also reported. 
 
 
a For LoVo S and LoVo R the mean values of diameter and volume are also reported. The Mg 
concentrations assessed by DCHQ5, expressed in nmol/106 cells were normalized to the 
respective mean volume to obtain the molar concentrations.  
SD, standard deviation; CV, coefficient of variation, the value of the t-test is also reported. 
 
 
In the cell population analysis the TRPM7 silencing in HUVEC cells did not affected 
the Mg content respect to the controls, while the content of Mg was different both in 
LoVo, (p<0.05) and in SaOS2 cells, (p<0.05). In particular, DCHQ5 chemosensor 
shown a high sensibility detecting a small difference between sensitive (18.4±1.4 
Cellular Model diameter volume volume
LoVo  (μm)  (μm3)  (L) (nmol/106cells) (mmol) (mM)
28.43 2.84E-11 16.6
34.07 3.41E-11 19.9
28.60 2.86E-11 16.7
33.99 3.40E-11 19.8
32.32 3.23E-11 18.9
32.81 3.28E-11 19.2
32.81 3.28E-11 19.2
29.13 2.91E-11 17.0
Mean 31.5 18.4
SD 2.2 1.3
CV 7% 7%
29.2 2.92E-11 20.5
27.8 2.78E-11 19.5
28.1 2.81E-11 19.7
33.0 3.30E-11 23.2
26.4 2.64E-11 18.6
28.6 2.86E-11 20.1
27.2 2.72E-11 19.1
32.0 3.20E-11 22.5
Mean 29.0 20.4
SD 2.1 1.5
CV 7% 7%
p value: 0.009
Resistant 14.0 1423 1.42E-12
DCHQ5 (cells population analysis)
[Mg]
Sensitive 14.8 1713 1.71E-12
 mM) and resistant (20.4±1.6 mM) LoVo cells, denoting a small coefficient of 
variation (7%).  
On the other hand, single cell analysis allow to reach the intracellular distribution of 
Mg but the technique is able to reveal only marked difference, as in the case of SaOS2 
cells.  
5.6 Single cell vs Cell population analyses 
An intrinsic limitation of the synchrotron-based fluorescence analyses is the 
reduction of the cellular volume that prevents the directly comparison of data of 
single cells with ones of cell population.  
Indeed, in order to preserve the chemical integrity and morphology of the cells, we 
used cryogenic methods of fixation which, as well as all the other available methods 
of fixation, provoke a reduction of the cellular volume, mainly because of the loss of 
the intracellular H2O.  
As a consequence, to compare the two approaches, we normalized the total 
magnesium concentration of each dehydrated cells calculated with single cells 
analysis with the mean volume of the corresponding cell population. 
This normalization allowed us to compare the molar Mg concentrations of single 
cells with the concentration calculated using DCHQ5 (Fig 5.13).  
 
  
 
Figure 5.13: Comparison of Total Mg concentrations in treated and controls HUVEC 
(top on the left), SaOS2 (top on the right) and LoVo (bottom) cells, assessed by two 
different techniques: DCHQ5 spectrofluorimetric assay and XRFM multimodal 
approach. Magnesium intracellular concentration was evaluated by DCHQ5 
fluorescence and synchrotron radiation referring to volume of the respective cell 
populations.  
* Significantly different from +Mg for SaOS2 cells and from LoVo S in LoVo cells, 
p<0.05. 
 
 
The results shown for all the three cell lines examined a smaller value using single 
cell analysis compare to cell population, but of the same order of magnitude.  
Lastly, we calculated the ratio between the molar concentrations of Mg obtained 
with the two approach (Tab. 5.7). 
  
Table 5.7: Ratio between the mean molar concentrations obtained by single cells 
and cell population analyses a 
 
 
a CTRL indicate the mean molar concentration of control cells for HUVEC, of +Mg sample for 
SaOS cells, and of for LoVo S sample for LoVo cells; Treated indicate the mean molar 
concentration of TRPM7 silenced cells for HUVEC, of -Mg sample for SaOS cells, and of for 
LoVo R sample for LoVo cells. 
 
 
It is worthy to note that the underestimation of single cells analyses is always of the 
same amount revealing a surprisingly constant number of about 0.3 for all the three 
cell lines. 
  
CTRL Treated
HUVEC 0.29 0.31
SaOS2 0.3 0.32
LoVo 0.35 0.28
Single cells / Cell population
 6 CONCLUSIONS 
Magnesium is one of the fundamental element for life, since it is still now recognized 
that biological processes strictly dependent on its availability, yet without a clear 
picture of its role. This is could be mainly due to the scarcity of versatile and 
sensitive analytical techniques. 
 The family of diaza-crown conjugated with two hydroxyquinoline arms represent a 
group of interesting dyes, where DCHQ5 is the most interestingly member, for a 
series of peculiar properties. In the study herein reported, we demonstrated that 
DCHQ5 is able to accurately quantify the total amount of Mg in a very “small” cellular 
population, of order of 25-50 x 103 cells/mL, by using a simple spectrofluorimetric 
assay [146].  
This unique analytical capability was fundamental for the investigation of the role 
of magnesium in the process of hASCs pre-commitment with a cocktail of know 
differentiating agents (HBR).  
Furthermore, DCHQ5 demonstrated to be a versatile tool for different applications: 
its higher intracellular retentions allow to perform cytofluorimetric assays and two-
photon confocal microscopy on whole and viable cells; its photochemical 
characteristic make it excitable in both UV and visible spectra, and the presence of 
different lifetimes allow to perform fluorescence life time imaging of intracellular 
Mg. 
Combining this characteristic we demonstrated that DCHQ5 lifetimes distribution 
are homogeneous inside the cells, and the high fluorescence observed in the cellular 
membranes is not due a prevalence of the longer lifetime in the lipophilic 
environment but to a major concentration of the complex dye-Mg in these regions. 
These results support the hypothesis of the Rubin’s theory about the signalling role 
of membrane bound magnesium [81]. In addictions, the high fluorescence at the 
perinuclear area is in agreements with the localization of magnesium store in 
mitochondria and endoplasmic reticulum [109], [133]. 
The performant analytical characteristic of DCHQ5, especially in terms of sensitivity, 
were further corroborate in the analyses of magnesium in multi drug resistance: 
 DCHQ5 was able to discriminate a very little but significant difference of magnesium 
among LoVo sensitive and resistant to doxorubicin [147]. 
Currently, DCHQ5 is the only one dye that possesses such accurate analytical 
characteristic, rendering this dye an important and fundamental tool for the study 
of magnesium homeostasis, especially when the poorly availability of samples is a 
limiting factor.   
In these work we also exploited innovative techniques of x-ray fluorescence 
microscopy by using a multimodal approach in order to achieve within the cells the 
spatial distribution of the concentration of magnesium and fundamental light 
elements for life. The combination of classical and innovative analytical techniques 
can shed new light in the comprehension of magnesium homeostasis, since “how 
much” but also the more challenging “where is” are challenging but essential 
questions to answer. 
 
In parallel, we also evaluated the role of magnesium in HBR pre-commitment of 
adipose derived mesenchymal stem cells.  
We found that in normal magnesium availability, HBR-induced preconditioning of 
hASCs is associated by an increase of total magnesium content during time and by a 
block in the G2/M phase of the cell cycle.  
Moreover, our results demonstrated that magnesium deprivation triggers a 
multilineage enrichments of HBR-induced preconditioning of hASCs, since the gene 
expression of several cell lineage markers are strongly enhanced when cells are 
grown in Mg-free medium.   
This is extremely important because the possibility to easily obtain a higher yield of 
stem cells reactive to start different commitments only by combining HBR with 
magnesium deprivation, is proof of principle in regenerative medicine.   
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